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Abstract
The 2014 “EU Industrial R&D Investment Scoreboard” (the Scoreboard) contains economic and financial data for the world’s top 
2500 companies ranked by their investments in Research and Development (R&D). The sample contains 633 companies based 
in the EU and 1867 companies based elsewhere. The Scoreboard data are drawn from the latest available companies’ accounts, 
i.e. usually the fiscal year 2013/14.
Key findings of the 2014 Scoreboard comprise:
- The world top 2500 R&D investors continued to increase their investment in R&D (4.9%), well above the growth of net sales 
(2.8%). The 633 EU companies increased R&D by 2.6% and decreased sales by 2.0%.
- Volkswagen leads the global ranking for the second consecutive year, showing again a remarkable increase of R&D (23.4%, 
up to €11.7bn). Second continues to be Samsung, showing also an impressive R&D increase of 25.4%.
- EU companies in the automobile sector, accounting for one quarter of the total EU’s R&D, continued to increase significantly 
their R&D (6.2%). This reflects the good performance of automobiles companies based in Germany (9.7%) that account for three 
quarters of this sector’s R&D in the EU.
- The  poor R&D performance of EU companies in high-tech sectors such as Pharmaceuticals (0.9%) and Technology Hardware 
and equipment (-5.4%) weighed down the total R&D increase of the EU sample. The overall amount invested in R&D by EU 
companies in high-tech sectors represents 40% of the amount invested by their US counterparts and the gap between the two 
company samples is increasing with time.
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The 2014 “EU Industrial R&D Investment Scoreboard” (the 
Scoreboard) contains economic and financial data for the 
world’s top 2500 companies ranked by their investments 
in Research and Development (R&D). The sample contains 
633 companies based in the EU and 1867 companies based 
elsewhere. The Scoreboard data are drawn from the latest 
available companies’ accounts, i.e. usually the fiscal year 
2013/14. 
Summary
Highlights 
• In 2013, the world top 2500 R&D investors, which account for about 90% of global industrial R&D, continued to 
increase their investment in R&D (4.9%), well above the growth of net sales (2.8%). The 633 EU companies among 
the top world 2500 R&D investors show an annual R&D investment growth rate of 2.6%, well below the world 
average. This is accompanied by a decrease in sales (-2.0%) and operating profits (-6.6%).
• The EU based carmaker Volkswagen leads the global ranking for the second consecutive year, showing again a 
remarkable increase of R&D investment in 2013 (23.4%, up to €11.7bn). Second continues to be Samsung, showing 
a very impressive R&D increase of 25.4%.
• An examination of Scoreboard company patent portfolios shows that the patents to R&D ratios are very much 
sector-specific. This is combined with a wide variation within sectors, determined by the individual technological 
profiles of companies and their degree of specialisation. The Pharmaceutical sector, one of the most technologically 
concentrated, is a good example, with some companies focused purely on pharmaceuticals but others specialised 
in medical technologies (Johnson & Johnson) or chemistry (Bayer) and some with substantial patenting activity in 
biotechnology (Roche).
• EU companies in the automobile sector, accounting for one quarter of the total R&D invested by the EU-633 
Scoreboard companies, continued to increase significantly their R&D investments in 2013 (6.2%). This reflects the 
good performance of automobiles companies based in Germany (9.7%) that account for three quarters of this 
sector’s R&D in the EU.  
• The poor R&D growth performance of EU companies in relevant high-tech sectors such as Pharmaceuticals & 
Biotechnology (0.9%) and Technology Hardware & Equipment (-5.4%) weigh down the total average R&D increase of 
the EU sample. The overall amount invested in R&D by EU based companies in high-tech sectors represents 43.3% 
of the amount invested by their US counterparts and the gap between the two company samples is increasing with 
time.
• The analysis of an extended EU-1000 sample shows a significant number of companies in high and medium-high 
R&D sectors with a healthy growth record of R&D and sales over the last several years. But more rapid growth 
of middle-size potential future leaders in key high-tech sectors is required to achieve the shift of the European 
industrial structure towards more knowledge-intensive and higher value added sectors. 
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In 2013, the top world R&D investors continued to 
increase their Research and Development investments 
by 4.9%, more than the growth of net sales (2.8%). 
This suggests the importance of R&D investments 
in a context of increased competition and economic 
uncertainty. 
Following the strong rebound in sales and R&D investments 
observed in the two years following the 2009 financial crisis, 
the sample of the 2500 Scoreboard companies that account 
for about 90% of the world’s industrial R&D entered a period 
of marked  sales growth slow-down in 2012 and 2013 (see 
Figure S.1).  Despite this downward trend in sales, companies 
continue to show a quite remarkable resilience in the level 
of their R&D investments which increased 4.9% in 2013. 
Capital expenditures seemed to be more affected, showing 
an annual growth rate of 2.9% in 2013. The number of 
employees for the world sample has remained stable (0.1%). 
Figure S1 below shows the longer-term R&D trends for a 
subset of Scoreboard companies with available data for the 
past nine years.
Figure S1. One-year R&D investment and net sales growth in the Scoreboard.
Note: For 1888 out of the top world 2500 companies in the Scoreboard with data for the whole period. 
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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The 633 EU companies among the top world 2500 R&D 
investors in 2013 show an annual R&D investment 
growth rate of 2.6%, well below the world average. 
This is accompanied by a decrease in both sales (-2.0%) 
and operating profits (-6.6%).  
This R&D growth rate of Scoreboard EU based companies is 
lower than that of their counterparts in the US (5.0%, despite 
a significant slow-down in sales growth, 2.0% in 2013) and 
Japan (5.5%, in this case coupled with a robust sales increase 
of 11.5% and an exceptional increase of profits, 57.7%). 
Figure S2 shows the R&D and sales trends since the start of 
the crisis in 2009 until 2013 for a subset of companies based 
in these three regions (which account for 82% of the total 
R&D investment made by the 2500 Scoreboard sample: USA 
36.0%, EU 30.1% and Japan 15.9%). 
Companies based in other world regions continue to show in 
2013 strong levels of R&D investment increases (8.1%), with 
South Korean ones leading the performance (16.6%), followed 
by the Chinese (9.8%) and the Taiwanese (7.5%). The sample 
of companies based in these three Asian countries account 
for more than 50% of the R&D invested in the “other world” 
region sample (18% of the Scoreboard total).
Figure S2. One-year R&D investment and net sales growth in the Scoreboard, by main world region.
Note: For 564 EU, 724 US and 375 Japanese out of the top world 2500 companies in the Scoreboard with data for the whole period. 
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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In 2013, the number of employees decreased for the US 
sample (-3.1%), remained constant for the EU one and 
increased for the Japanese (2.7%). For the period 2005-
2013, the employment increase observed for the set of 
EU companies for which data is available (18.9%), is led 
by increases in high R&D-intensive sectors (40.1%) and 
medium-high sectors (25.1%). Note from figure S3 the very 
large fraction of EU employment contributed by low R&D 
intensity sectors.
Figure S3. Employment figures in the Scoreboard, by sector group and main world region.
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Note: For 476 EU, 525 US and 362 Japanese out of the top world 2500 companies in the Scoreboard with data for the whole period. 
Sectors are split into four groups according to the R&D intensity of the sector worldwide:
High R&D intensity sectors (R&D intensity above 5%) include e.g. Pharmaceuticals & biotechnology; Health care equipment & services; Technology 
hardware & equipment; Software & computer services; Aerospace & defence.
Medium-high R&D intensity sectors (between 2% and 5%) include e.g. Electronics & electrical equipment; Automobiles & parts; Industrial engineer-
ing & machinery; Chemicals; Personal goods; Household goods; General industrials; Support services.
Medium-low R&D intensity sectors (between 1% and 2%) include e.g. Food producers; Beverages; Travel & leisure; Media; Oil equipment; Electricity; 
Fixed line telecommunications.
Low R&D intensity sectors (less than 1%) include e.g. Oil & gas producers; Industrial metals; Construction & materials; Food & drug retailers; Trans-
portation; Mining; Tobacco; Multi-utilities.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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The EU based carmaker Volkswagen continues to lead 
the world R&D ranking, showing again a remarkable 
increase of R&D investment in 2013 (23.4%, up 
to €11.7bn). The second in the ranking, Samsung 
Electronics from South Korea, keeps the pace, and 
increases R&D by 25.4%, up to €10.2 bn.  The highest 
riser in the top 10 is Google at #9 in the 2014 ranking 
but it was only #182 in the 2005 Scoreboard.
Two companies enter the top 10 ranking in this Scoreboard 
2014 edition: Google (9th) from USA (after climbing 173 
positions since its entry into the Scoreboard ranking) and 
Daimler (10th) from the EU. These two companies replace 
the US based pharma companies Pfizer (now 15th, from 
10th last year) and Merck (now 12th, from 8th last year). 
The USA based ICT companies Microsoft and Intel retain the 
third and fourth position, followed by the two Swiss pharma 
companies Novartis (5th) and Roche (6th). Toyota (7th) from 
Japan and Johnson & Johnson (8th) complete the top 10.
Among the top R&D companies, those showing the largest 
increase in R&D are Celgene, US (39.0%); Apple, US (32.4%); 
Otsuka, Japan (29.4%); Qualcomm, US (26.9%); Samsung 
Electronics, South Korea (25.4%). Those showing the largest 
decrease in R&D are Abbot Laboratories, US (-66.4% 
due to a demerger); Peugeot (PSA), France (-20.8%); 
STMicroelectronics, The Netherlands (-19.2%); Texas 
Instruments, US (-18.9%), Nokia, Finland (-17.1%).
The top 100 companies, accounting for 53.1% of the total 
R&D investment made by the 2500 Scoreboard companies, 
include 31 based in the EU, 39 in the US and 17 in Japan. For 
these companies, only around one third of the ones based 
in the EU have increased their R&D investment in 2013, 
compared to more than two thirds in the case of companies 
based in the US and Japan. 
Among the top 100 group, 31 companies have at least 
doubled their R&D investment since 2005 (8 companies 
based in the EU and 15 from the US). This group of 
companies is mainly from high R&D-intensive sectors, 23 of 
them have increased net sales by more than 100% and 17 
companies increased employment by more than 100%. A 
number of the large increases are for companies that have 
made substantial acquisitions.
World top 100 R&D investors in the Scoreboard 
ranking are responsible for an important portion 
(around one third) of all the patents filed at the US 
and EU patent offices. Companies in the Electronic and 
Electrical Equipment sector show the highest patent 
propensity, with Samsung Electronics being, together 
with IBM, the most active among the top 100 R&D 
investors.
This Scoreboard edition includes for the first time an analysis 
of the patent portfolios of the top 100 R&D investors (based 
on The 2014 Scoreboard ranking and for the period 2010-
2012). Results show that the patent propensity (patents to 
R&D ratio) is very much sector specific with the Electronic 
and Electrical Equipment sector showing the highest 
patent propensity, about ten times larger than that of the 
Pharmaceuticals & Biotechnology sector (see figure S4). 
This explains many of the differences observed in patent 
statistics between countries and regions; they are due to 
sector mix effects. 
At the same time, the patent propensity observed for 
companies classified in the same industrial sector can vary 
substantially, as this depends on the individual technological 
profiles of companies, characterised by multiple degrees of 
specialisation/diversification. The sectors with the higher 
degree of technological specialisation are Technology and 
Hardware Equipment and Pharmaceutical and Biotechnology. 
Further analysis of Scoreboard companies’ patent portfolios 
could help in the future to improve its characterisation 
and to analyse their role in the development of important 
technologies. From this first analysis of the top 100 R&D 
investors, we observe that companies in the Chemicals, 
Electronic & Electrical Equipment, General Industrials 
and Pharmaceutical & Biotechnology sectors have the 
highest proportions of patents related to key enabling 
technologies (industrial biotech, nanotechnology, micro- 
and nano-electronics, advanced materials and advanced 
manufacturing technologies).
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EU companies in the automobile sector, accounting 
for one quarter of the total R&D invested by the 
EU-633 Scoreboard companies, continue to increase 
their R&D investments in 2013 but at a slower pace 
than in 2012, in the context of a marked slowdown 
of sales growth. 
EU companies in the automobiles and parts sector showed 
a slow-down in the pace of their R&D investment growth 
(6.2%, well below last year’s growth rate of 14.4%), 
which remains however well above sales growth (1.8%). 
While companies based in Germany and the UK showed 
strong R&D growth (9.7% and 9.5% respectively), French 
automobile firms decreased R&D by 8.9%.  Japanese 
counterparts showed in contrast remarkably higher R&D 
and sales growth rates (11.0% and 16.1% respectively), 
with USA ones performing well in sales (4.9%) and with 
R&D growth of 5.6%, below the world sector’s average 
(7.1%).
EU companies in other relevant medium high-tech sectors 
show moderate R&D growth rates (Industrial Engineering 
0.9%, Chemicals 3.1%, Electronic & Electrical Equipment 
5.4%), in all cases above the results shown by their US 
counterparts. This corresponds to sluggish (or slightly 
negative) sales growth in these sectors.
Figure S4. Patent Propensity of the 2013 Scoreboard companies by main industry.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
Number of patents/€m
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Companies in high-tech sectors showed mixed results 
across world regions. Software & Computer Services 
significantly increased R&D and sales (11.4% and 
7.2%) while Pharmaceuticals & Biotechnology (2.4% 
and 2.8%) and Technology Hardware & Equipment 
(3.3% and 2.2%) showed much modest figures.
The poor R&D performance of EU companies in relevant 
high-tech sectors such as Pharmaceuticals & Biotechnology 
(0.9%) and Technology Hardware & Equipment (-5.4%) 
weighed down the total average R&D increase of the EU 
sample. The continued good performance of the EU Software 
and Computer Services (7.9%) has limited impact in overall 
trends given the significant relative smaller size of its 
companies.
The share of high-tech companies in the US Scoreboard 
sample continues to increase, with Software and Computer 
Services (accounting for 19.7% of the R&D invested 
by the total US sample) and Technology Hardware and 
Equipment (accounting for 24.8% of total US) showing R&D 
investment growth of 12.0% and 6.5% respectively. The 
good performance of these two ICT sectors compensates the 
stagnating pace of R&D of the US pharma sector (-6.6%). 
The relatively slow growth of the US pharma sector masks 
the high R&D growth (over 20% per year) of the main US 
therapeutic biotech companies.
The result of the above described trends is an 
increasing negative gap between the overall amounts 
invested in R&D by EU based companies in high-
tech sectors and the amounts invested by their US 
counterparts (Figure S6). 
Except for the sector of Aerospace & Defence, US Scoreboard 
companies operating in high R&D intensive sectors invest 
more than their EU counterparts, as illustrated in figure 
S6. More striking differences, both in terms of number of 
companies and overall R&D investment values correspond 
to the ICT sectors of Software, Semiconductors, Computer 
Hardware, Internet and Computer Services and to the health 
related sector of Biotechnology. In 2013, the overall R&D 
investment in high-tech sectors of the EU Scoreboard 
companies was €61.8bn well below the total amount 
invested by their US counterparts, €142.8bn.
Figure S5.  R&D and Net Sales growth in the Automobiles & Parts Sector – 2011-2012 vs 2012-2013 for 
EU, US and Japan based companies.
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Note:  The left hand bar refers to 2011/12, the right hand to 2012/13.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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Figure S6. US-EU R&D gap 2013 in the high-tech sectors (€ billion).
Note:  Between brackets the number of companies for each country. Leisure Goods and Electronic Office Equipment not represented in the figure due to 
the low number of companies.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
S u m m a r y
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Analysing the R&D investment trends for the period 2005-
2013 for a subsample of EU and US companies in this year 
Scoreboard ranking (Figure S7), we observe a rather static 
picture in terms of sectoral specialisation in the EU (with 46% 
of investments by the medium-high R&D intensive sectors) 
and a reinforcement of the high-tech sector prominence 
in the US (74% of the total’s sample R&D investment vs. 
68% in 2005). The US automotive sector has at the same 
time decreased in importance with GM and Ford in the top 
6 global companies in the 2005 Scoreboard but at the #11 
and #17 positions this year.
Figure S7. R&D investment of EU and US companies by sector group.
Note:   * R&D amounts for 503 EU and 681 US of the top world 2500 companies in the Scoreboard with data for the whole period.  
Sectors split according to figure S3.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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A more detailed analysis of an extended sample of the 
top EU-1000 R&D investors shows that the current 
population of top R&D investors could constitute a 
good basis on which to promote the necessary shift 
of the European industrial structure towards more 
knowledge-intensive sectors. Stronger economic 
efficiency for some of the current leading innovators 
and more rapid growth of middle-size potential future 
leaders in key high-tech sectors will be required.
An analysis of the middle-sized companies populating the 
bottom half of the EU 1000 sample, shows a substantial 
number of companies in high and medium-high R&D sectors 
with a healthy growth record of R&D and sales over the 
last years. The sectors of Software & Computer Services, 
Pharmaceuticals & Biotechnology, Industrial Engineering and 
Electronic & Electrical Equipment concentrate the largest 
number of good performers in this subsample. In the bottom 
half of the 1000 sample, the number of good performers 
located in Sweden is particularly high. 
It is worth mentioning that despite the relatively high number 
of entries and exits for the 500 companies in the lower part 
of the EU-1000 ranking, 38% of companies present in the 
ranking before the crisis (2007) have survived and 26% have 
been acquired. Among the survivors, one fifth managed to 
climb to the top EU-500 part of the ranking.
The analysis of company performance in terms of the Value 
Added (VA) created by the EU companies shows significant 
differences both between and within industrial sectors. 
The ratio of VA to net sales of the Software & Computer 
Services sector is more than twice that of the Automobiles 
& Parts sector. The largest ratio of VA to costs of resources 
(wealth creation efficiency) is found in Pharmaceuticals & 
Biotechnology, three times more ‘efficient’ than the Electronic 
& Electrical Equipment sector. At company level, great 
differences are observed within the sectors. For example, 
among the top 10 R&D investors in the Chemicals sector 
(Figure S8), Solvay shows the highest ratios of VA to net 
sales and cost of resources (50.0% and 227.5% respectively) 
whereas Lanxess shows the lowest ones (23.6% and 98.8% 
respectively).    
Figure S8.  Ratio of VA to net sales vs VA to cost of resources for the top 10 R&D investors in the EU 
Chemical sector.
Source: The 2014 EU Industrial R&D Investment Scoreboard
 European Commission, JRC/DG RTD.
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Introduction
In 2014, we increased the scope of the “EU Industrial R&D 
Investment Scoreboard” (the Scoreboard)1 improving its 
capacity to monitor and analyse worldwide trends in industrial 
R&D. For background information on the Scoreboard please 
see Annex 1.
In this year’s edition, the Scoreboard comprises the 2500 
companies investing the largest sums in R&D in the 
world and an additional number of companies to cover the 
top 1000 R&D investing companies based in the EU2. 
In total, there are 2867 companies incorporated in the 2014 
Scoreboard.
In order to avoid double counting, the Scoreboard considers 
only data from parent or independent companies. Normally, 
these companies integrate into their consolidated accounts 
the data of their subsidiary companies. An analysis of the 
ownership structure of the parent companies included in the 
2014 Scoreboard finds that they have more than 600.000 
subsidiary companies (controlled companies with more than 
50% ownership).
Companies’ R&D rankings are based on information taken 
from the companies’ latest published accounts. For most 
companies these correspond to calendar year 2013, but 
significant proportions have financial years ending on 31 
March 2014 (Japanese companies in particular). There are 
few companies included with financial years ending as late 
as end June 2014 and a few for which only accounts to end 
2012 were available.
The representativeness of the Scoreboard has improved 
in terms of industrial coverage and geographic scope. This 
edition includes companies based in 48 countries of which 20 
are Member States of the EU. A wide range of manufacturing 
and services sectors is represented, including more than 50 
industries with a special focus on most innovative ones such 
as ICT, health, transport and engineering related industries. 
However, it should be noticed that the Scoreboard relies 
1  The EU Industrial R&D Investment Scoreboard is published annually by the European 
Commission (JRC-IPTS/DG RTD) as part of its Industrial Research and Innovation 
Monitoring and Analysis activity (IRIMA). 
2  In this report, the term EU company refers to companies whose ultimate parent has 
its registered office in a Member State of the EU. Likewise, non-EU company applies 
when the ultimate parent company is located outside the EU (see also the glossary and 
definitions in Annex 2 as well as the handling of parent companies and subsidiaries).
on disclosure of R&D investment in companies’ published 
annual reports and accounts and that due to different 
national accounting and disclosure practices, companies 
of some countries are less likely than others to disclose 
R&D investment consistently. For these reasons, companies 
from some countries such as Southern or Eastern European 
countries might be under-represented while others such as 
the companies from the UK over-represented.  
The overall coverage in terms of total R&D is similar as in 
previous editions. The total amount of R&D investment of 
companies included in the Scoreboard is equivalent to more 
than 90% of the total expenditure on R&D financed and 
performed by the businesses sector worldwide3. 
The Scoreboard collects key information to enable the 
assessment of the R&D and economic performance of 
companies. The main indicators, namely R&D investment, 
net sales, capital expenditures, operating profits and number 
of employees are collected following the same methodology, 
definitions and assumptions applied in previous editions. This 
ensures comparability so that the companies’ economic and 
financial data can be analysed over a longer period of time. 
The data have been collected by Bureau van Dijk Electronic 
Publishing GmbH, following the same approach and 
methodology applied since the first Scoreboard edition 
in 2004. Please see the main methodological limitations 
summarised in Box I.1 and detailed methodological notes 
in Annex 2.
The capacity of data collection is being improved by 
gathering information about the ownership structure of 
the Scoreboard parent companies and the main indicators 
for their subsidiaries.  In 2014, we have collected available 
indicators reported by the more than 600.000 subsidiary 
companies involved in this Scoreboard edition. This allows a 
better characterisation of companies, in particular regarding 
the sectoral and geographic distribution of their research 
and production activities and the related patterns of growth 
and employment.
3  According to the latest figures reported by Eurostat, i.e. BERD financed by the 
business enterprise sector in 2010 compared with R&D figures in the 2011 Scoreboard.
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Companies’ behaviour and performance can be analysed 
over longer time periods using our history database that 
contains information on the top R&D companies since 
2003. This enables benchmarking analyses of companies 
across sectors and countries, for example the identification 
of companies showing outstanding economic or innovation 
results and the analysis of the main factors underlying such 
successful dynamics.
This report concentrates on the analysis of the world’s 
top 2500 companies that all invested more than 
€15.5 million in R&D in 2013. The sample comprises 
companies based in the EU (633), the US (804), Japan 
(387) and other countries (676) including China, 
Taiwan, South Korea, Switzerland, the Cayman Islands, 
India, Canada, Australia, Israel, Norway, Bermuda, 
Brazil and a further 14 countries (see Figure I.1).  
A sample consisting of the top 1000 R&D investing 
companies based in the EU is analysed separately in 
chapters 5 and 6; these all have R&D investments 
exceeding €5.0 million.
The characteristics of the sample of 2500 companies used 
for most of the analysis are summarised in Table I.1.
Table I.2 presents the distribution of the sample by groups 
of companies in terms of number of employees. This table 
shows the high concentration of R&D and net sales by large 
companies, i.e. companies with more than 5000 employees 
concentrate 90% of R&D investment and 95% of net sales.
The sector and country composition of the EU 1000 sample 
is found in Annex 3. 
This edition shows that companies continued to increase 
R&D investments in 2013 at a significant pace, higher than 
the growth rate of revenues. This report also shows a great 
variety in company R&D and economic patterns across 
industries and between countries, reflecting important 
differences in market conditions and economic background 
throughout the world. 
Report structure 
Chapter 1 presents the worldwide trends of industrial R&D. 
It provides an overview of the main indicators for the top 
2500 companies ranked by level of R&D investment and the 
main changes that took place over the last year. An analysis 
of the main indicators of the company data aggregated by 
world regions is included together with the performance of 
companies over the past 10 years.
The performance of individual companies among the top 
R&D investors is provided in chapter 2. The list of the top 
world 100 R&D companies is examined highlighting those 
companies showing remarkable R&D and economic results 
and improvement in the R&D ranking over the last 10 years.
Chapter 3 presents an analysis of the technological 
specialisation of companies based on the examination of 
the patent portfolio of the top R&D investors focussing on 
the assessment of company capacity to develop relevant 
technologies. The analysis includes the comparison of R&D 
investment and patent activity of the top R&D companies 
aggregated by main industry. 
Chapter 4 presents an analysis of the main R&D and 
economic indicators of companies aggregated by industrial 
sector, with comparisons of EU companies and their main 
worldwide counterparts. 
Chapter 5 discusses the trends on R&D and economic 
performance of the companies included in the extended 
sample comprising the top 1000 R&D investors based in 
Member States of the EU. 
Chapter 6 identifies potential leading innovators in the EU. 
It is based on a sample of the 500 companies at the lower 
reach of the EU 1000 ranking. It analyses their R&D and 
economic performance over the years and underlines the 
main dynamics of their investment strategies. 
Annex 1 provides background and methodological information 
about how the Scoreboard is prepared. The methodological 
approach of the Scoreboard, its scope and the limitations are 
described in Annex 2 and the listing of companies ranked by 
their level of R&D investment is provided in Annex 3.  
The complete data set is freely accessible online at: http://iri.
jrc.ec.europa.eu/scoreboard14.html
In the next edition, this website will allow user-friendly and 
interactive access to the individual company data or to 
groups of companies aggregated by industrial sector and 
country.  
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Table I.1 Distribution of the 2014 Scoreboard companies by country and sector.
633 companies based in the EU
Companies 
by country
United Kingdom 140;  Germany 138;   France 89;   Sweden 52;   Netherlands 41;   Italy 37; 
Finland 29;   Denmark 25;   Austria 17;   Ireland 17; Spain 17;  Belgium 14;   Luxembourg 
6 ;  Portugal 4 ;  Greece 2;   Czech Republic 1 ; Hungary 1;  Malta 1;  Poland 1;  Slovenia 1 
The 10 most 
numerous 
sectors 
Industrial Engineering 72; Pharmaceuticals & Biotechnology 67; Software & Computer 
Services 50;  Electronic & Electrical Equipment 49;  Automobiles & Parts 39; Technology 
Hardware & Equipment 35; Chemicals 27; General Industrials 24; Banks 23; Health Care 
Equipment & Services 23. 
The top 5 sectors account for 43.8% of the 633 EU companies.
1867 companies based in non-EU countries
Companies 
by country
US 804;   Japan 387;   China 199;  Taiwan 104;  South Korea 80;  Cayman Islands 62; 
Switzerland 62;  Israel 26;  Canada 25;  India 24;   Bermuda 19;  Australia 15; Norway 12; 
Brazil 9 and further 14 countries.
The 10 most 
numerous 
sectors 
Technology Hardware & Equipment 299; Pharmaceuticals & Biotechnology 227;  Software 
& Computer Services 218;   Electronic & Electrical Equipment 193; Industrial Engineering 
140; Chemicals 112; Automobiles & Parts 109; Health Care Equipment & Services 74; 
General Industrials 71;  Construction & Materials 53. 
The top 5 sectors account for 57.7% of the 1867 non-EU companies.
Source:   The 2014 EU Industrial R&D Investment Scoreboard.
               European Commission, JRC/DG RTD.
Table I.2   Distribution of companies in the 2014 Scoreboard by size classes.
Number of employees Number of companies
R&D per 
company (€m)
Net sales per 
company (€m) R&D intensity (%)
Less than 250 (SMEs) 93 49.0 621.0 7.9
251 - 1000 256 37.4 198.0 18.9
1001 - 5000 604 54.7 863.6 6.3
5001 - 10000 370 109.0 2768.5 3.9
More than 10000 825 479.3 15632.6 3.1
Total 2148 224.8 6774.3 3.3
Note: Only 2174 companies out of the 2500 reported number of employees. 
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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Figure I.1  Distribution of  the 2500 companies in the 2014 Scoreboard by country.
    
Source: The 2014 EU Industrial R&D Investment Scoreboard; European Commission, JRC/DG RTD.
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4  Since 2005, the European Union requires all listed companies in the EU to prepare 
their consolidated financial statements according to IFRS (see: EC Regulation No 
1606/2002 of the European Parliament and of the Council of 19 July 2002 on 
the application of international accounting standards at http://eur-lex.europa.eu/
LexUriServ/LexUriServ.do?uri=CELEX:32002R1606:EN:HTML).
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Box I.1  Methodological caveats.
Users of Scoreboard data should take into account the methodological limitations summarised here,  especially when 
performing comparative analyses (full description of methodology is found in Annex 2): 
A typical problem arises when comparing data from different currency areas.  The Scoreboard data are nominal and 
expressed in Euros with all foreign currencies converted at the exchange rate of the year-end closing date (31.12.2013). 
The variation in the exchange rates from the previous year directly affects the ranking of companies, favouring those 
based in countries whose currency has appreciated with respect to the other currencies. In this reporting period, the 
exchange rate of the Euro against main currencies changed as follows:  the Japanese Yen significantly depreciated by 
27%, the US dollar depreciated by 6.6% and the pound sterling remained practically unchanged. 
The growth rate of the different indicators for companies operating in markets with different currencies is affected 
in a different manner. In fact, companies’ consolidated accounts have to include the benefits and/or losses due to 
the appreciation and/or depreciation of their investments abroad. The result is an ‘apparent’ rate of growth of the 
given indicator that understates or overstates the actual rate of change. For example, this year the R&D growth rate 
of companies based in the Euro area with R&D investments in Japan is partly understated because the ‘losses’ of 
their overseas investments due to the important appreciation of the Euro against the Japanese yen (from ¥114.2 to 
¥145.1). Conversely, the R&D growth rate of Japanese companies is partly overstated due to the ‘benefits’ of their 
investments in the Euro area. Similar effects of understating or overstating figures would happen for other indicators, 
e.g. for net sales. 
When analysing data aggregated by country or sector, be aware that in many cases, the aggregate indicator depends 
on the figures of a few firms. This is due, either to the country’s or sector’s small number of firms in the Scoreboard or 
to the indicator dominated by a few large firms.
The different editions of the Scoreboard are not directly comparable because of the year-on-year change in the 
composition of the sample of companies, i.e. due to newcomers and leavers. Every Scoreboard comprises data of 
several financial years allowing analysis of trends for the same sample of companies.
In most cases, the companies’ accounts do not include information on the place where R&D is actually performed; 
consequently the approach taken in the Scoreboard is to attribute each company’s total R&D investment to the country 
in which the company has its registered office. This should be borne in mind when interpreting the Scoreboard’s country 
classification and analyses.
Growth in R&D can either be organic, the outcome of acquisitions or a combination of the two. Consequently, mergers 
and acquisitions may sometimes underlie sudden changes in specific companies’ R&D growth rates and/or positions in 
the rankings.  Demergers can result in substantial reductions of R&D with the emergence of new, demerged companies.
Other important factors to take into account include the difference in the various countries’ (or sectors’) business cycles 
which may have a significant impact on companies’ investment decisions, and the initial adoption or stricter application 
of the International Financial Reporting Standards (IFRS)4. 
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This chapter provides an overview of main trends in R&D 
and economic indicators of the top 2500 R&D companies 
that each invested more than €15.5 million in R&D in 20135. 
It includes the analysis of the long-term performance of 
companies aggregated by main world regions.  
As in the previous year, the average growth rate of companies’ 
R&D investments in 2013 was significantly higher than the 
growth rate of their sales revenues. 
R&D investments and economic results in 2013 show 
important variations across world regions and industries. 
This reflects a continued weak and uneven recovery of the 
global economy and persistent market uncertainties. The 
potential growth rate is still uncertain since the beginning 
of the financial crisis in developed countries as well as in 
emerging economies.
Factors underlying the regional changes observed include the 
different policies aimed at stimulating further the recovery of 
the economy and the weakness of many banks following the 
financial crisis which has limited their lending to companies 
and therefore limited growth for some. Higher GDP growth is 
being seen in the US and the UK following the quantitative 
easing of their central banks. In Japan, the impact of radical 
fiscal and monetary policies, structural reforms and the 
devaluation of the yen are being perceived in companies’ 
results. The Eurozone shows a lower GDP growth with the 
heavy burden of unemployment and remaining problems in 
the financial system. In China, a somewhat slower growth 
than in previous years is now being observed.
5 Due to data availability some companies may be missed, please see methodological 
limitations in Annex 2.
Key findings
• The top 2500 Scoreboard companies invested in R&D 4.9% 
more in 2013 than in 2012, following the increase of 6.8% 
in the year before. The net sales of the 2500 companies 
increased much less than R&D, at 2.8%, compared with 
the net sales increase of 4.0% in 2012.
• The 633 EU companies increased R&D investment by 2.6% 
while decreasing net sales by 2.0%. The 804 US companies 
reported a significant increase in R&D (5.0 %) but a lower 
increase in net sales (2.0%). The 387 Japanese companies 
showed a good performance increasing R&D by 5.5% and 
net sales by 11.5%. 
• Companies outside of the EU, the US and Japan (the OC 
group) continued to show the best performance in terms of 
R&D (8.1%) and increasing net sales by 5.5 %. The largest 
increases in R&D investment in this group were reported by 
companies based in South Korea (16.6 %), China (9.8 %), 
and Taiwan (7.5%).
• Trends over the past 8 years show that companies based 
in the EU significantly slowed-down in 2013 the recovery 
of the R&D growth that followed the crisis in 2009, in a 
context of negative sales and profits. R&D growth of their 
US counterparts appears more resilient. This resilience in 
US growth is associated with strong growth in high tech 
sectors such as software and biotech. Japanese companies, 
hit hard by the crisis and the earthquake, showed positive 
results in the last year in terms of R&D, and especially 
regarding the growth rate of net sales and profits.
1 Worldwide trends in corporate 
R&D
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1.1 Indicator changes over the 
last year
The main economic and financial indicators for the year 
2013 for the set of 2500 companies are summarised in 
Table 1.1. The table includes the indicators of the top 100 
R&D investing companies to show their high weight on the 
whole sample.
• The positive trends on R&D investment continued in 2013 
for the fourth consecutive year. The 2500 Scoreboard 
companies invested €538.5 billion in R&D, 4.9% more 
than in 2012, following the increase of 6.8% in the year 
before. Seventy per cent of the companies showed positive 
R&D growth in 2013.  
• For the second consecutive year net sales increased less 
than R&D. In 2013, the growth rate of net sales of the 
2500 companies was 2.8%, lower than the 4.0% of 2012. 
Company results in terms of operating profits improved 
significantly compared with the previous year: 83% of 
companies made profits in a much larger proportion than 
the 17% of companies that presented losses.
• Company investment in fixed capital continued to 
grow but at a slower pace, at 2.9%, compared with the 
previous year’s increase of 9.1%. Capital expenditure as 
a percentage of net sales (7.2%) remained practically the 
same than the previous year (7.2%).
• The number of employees of the 2500 companies in the 
Scoreboard slightly increased by 0.1%. 
• The top 100 R&D companies account for 53.1% of the 
total R&D of the 2500 sample but only 27.0% of the total 
sales. This is mainly due to the large oil companies (Shell, 
China Petroleum, Exxon, BP, Total, Chevron and Petroleo 
Brasileiro) that are not among the top 100 R&D investors, 
but account for 10% of the total sales of the 2500 
companies.
6 Compound annual growth rate.
7 Fixed capital investment
Table 1.1 Overall performance of companies in the 2014 Scoreboard. 
Factor Top 100 R&D investors Top 2500 R&D investors
Total R&D investment in 2013, € bn 285.8 538.3
One-year change, % 3.7 4.9
CAGR6 3yr, % 5.5 6.4
Net Sales, € bn 4514.8 16723.0
One-year change, % 3.2 2.8
CAGR  3yr, % 5.3 5.5
R&D intensity, % 6.3 3.2
Operating profits,  € bn 529.0 1555.4
One-year change , % 17.8 8.2
Profitability, % 11.8 9.3
Capex7, € bn 300.3 1087.7
One-year change , % 4.8 2.9
Capex / net sales, % 7.0 7.2
Number of employees, million
One-year change, %
11.5
0.0
48.6
0.1
Note: Calculation of growth rates and ratios include only companies for which data are fully available.
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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1.2 R&D trends by world region
This section analyses the overall R&D and economic 
performance of the Scoreboard companies according to the 
location of their registered offices in the main world regions.
The 2500 companies are grouped into four main sets: the top 
633 companies from the EU, 804 companies from the US, 
387 from Japan and 676 companies from other countries 
(OC). ‘Other countries’ includes companies from China (199), 
Taiwan (104), South Korea (80), Switzerland (62), Cayman 
Islands (62), Israel (26), Canada (25) and companies based 
in a further 19 countries.
Figure 1.1 and table 1.2 summarise the companies’ indicators 
aggregated by main world region. Table 1.3 shows the main 
indicators for countries included in the OC group.
The R&D investment of the 633 EU companies continued to 
grow in 2013 but at lower pace, 2.5%, compared with 6.8% 
in 2012. On the contrary, the net sales of the EU companies 
decreased by 2.0% while in 2012 net sales had risen by 
3.8%.
The overall R&D and net sales of the EU group are largely 
driven by the performance of German companies that 
account respectively for 36.6% and 26.5% of the EU’s total 
R&D and net sales. The 138 German companies in the 
EU-633 group increased R&D by 6.0% but decreased net 
sales by 1.3%.  These results reflect to a large extent the 
performance of the German companies in the Automobiles 
& Parts sector (growth rate of 9.7% in R&D and 2.3% in 
net sales). This sector accounts for more than 50% of R&D 
and 33% of net sales of the group of German companies 
(see Chapter 5). Regarding the other two largest Member 
States of the EU, companies based in the UK increased 
R&D by 5.2% and reduced sales by 0.5%. In contrast French 
companies saw a decrease of R&D and net sales by 3.4% 
and 3.9% respectively.
The group of US companies increased R&D investment at 
similar rate than the world’s average, at 5.0% but like in 
the past year, they had a much lower net sales growth rate, 
2.0%. 
Japanese companies overperformed EU and US firms in 
terms of R&D (5.5%) and especially in terms of net sales 
(11.5%).  As in the case of German companies, the average 
performance of Japanese companies is strongly dependent 
on the results of the Automobiles & Parts sector, largest 
Japanese sector that showed an increase of 11.0% in R&D 
and 16.1% in net sales.
Companies based outside of the EU, US and Japan (the OC 
group) continued to increase substantially the R&D investment 
(8.1%) and also net sales (5.5%), at a more moderate pace 
but well above the world average’s rate. The largest increase 
in R&D investment was reported by the 80 companies based 
in South Korea (16.6%). The South Korea group is dominated 
by companies from the Electronic & Electrical Equipment 
sector and particularly by the outstanding performance of 
the company Samsung Electronics that accounts for more 
than 50% the total R&D, up by 25.4% in 2013. 
Other companies from main investing countries in the OC 
group, that showed large increases in R&D, were those based 
in China (9.8%) and Taiwan (7.5%). The companies based 
in Switzerland, the largest R&D investing country of the OC 
group (world R&D share of 4.2%) increased R&D in 2013 by 
3.6%.  The increasing group of companies with headquarters 
in the Cayman Islands8, 62 (49 in The 2014 Scoreboard), 
operating especially in ICT industries, the 2013 increased 
their R&D by 21%.  
Compared with last year’s Scoreboard, the EU and US 
companies’ share of total R&D investment rose by 0.8 
percentage points (from 29.3 % to 30.1 % and 35.2% to 
36.0% respectively).  Following the trend of recent years, 
the share held by the Japanese companies continued to fall 
sharply, from 18.9% to 15.9%, and that of the companies 
based in other countries increased significantly, overpassing 
the Japanese share, from 16.6% to 18.0%. 
The average R&D intensity of companies based in the EU, the 
US and other countries increased due to a higher growth rate 
of R&D investments compared with the growth rate of net 
sales. The opposite happens for companies based in Japan 
that showed a growth rate of sales twice than that of R&D.  
In 2013, average company capital expenditure decreased 
slightly for EU companies (-0.5%) following an important 
increase in the previous year. Companies in the other regions 
continued to increase capital expenditure but at lower pace 
compared with 2012. The highest increase was for the 
Japanese companies (7.5%), followed by the companies 
from the OC group (4.4%) and the US companies (3.0%).         
Companies based in the EU showed a decrease in operating 
profits (-6.6%) however less pronounced than the tough 
decrease in 2012 (-24.3%). Companies based in the other 
three regions increased profits in 2013 with Japanese 
companies showing an impressive 57.7% increase mostly 
contributed by the Automobiles & Parts sector and particularly 
due to Toyota, the top R&D investor that increased profits 
by 73.5%. However, despite the big increase in profitability 
by the Japanese group, Japan has the lowest profitability at 
5.7% compared to the EU at 6.9% and the US at 13.9%.  The 
US companies and those from the OC group increased profits 
by 10.6% and 9.9% respectively.  The profitability (operating 
profits as percentage of net sales) changed according to the 
difference between the growth rate of sales and profits. 
8 There is evidence that most of these companies are headquartered in the Cayman 
Islands for fiscal reasons (as well as those based in Bermuda and other countries) 
while, according to their subsidiaries, their main activities are located in different 
countries. An increasing number of companies is taking advantage of low corporate 
taxes and may be responsible of unexpected results when analysing the Scoreboard 
data aggregated at country and region levels. 
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The average profitability of the EU companies decreased 
while that of Japanese companies recovered significantly 
and the profitability of the US and the OC group remained 
level.   
As underlined in previous editions, most of the differences 
in R&D intensity and profitability between regions and 
countries are related to differences in sector mix. The US 
is by far the strongest region in the group of high R&D 
intensity sectors including pharmaceuticals, health, 
software, and technology hardware whereas the EU and 
Japan are stronger in medium R&D intensity sectors like 
the automotive sector (see chapter 4).
Figure 1.1  R&D investment by the top 2500 companies, by main world region (% of total €538.3bn).
Note:  R&D shares of other EU countries (with number of companies in brackets): Ireland 0.7% (17), Denmark 0.7% (25), Belgium 0.4% (14), Austria 
0.2% (17), Luxembourg 0.1% (6) and further 7 countries with less than 5 companies each (Portugal, Hungary, Slovenia, Greece, Czech Republic, 
Malta and Poland).
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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Table 1.2  Overall performance of the 2500 companies in the 2014 Scoreboard.
Factor EU USA Japan Other countries
No. of companies 633 804 387 676
R&D in 2013, € bn 162.3 193.6 85.6 96.8
World R&D share, % 30.1 36.0 15.9 18.0
One year change, % 2.6 5.0 5.5 8.1
CAGR 3yr, % 5.8 7.0 3.0 9.8
 Net Sales, € bn 5909.0 3839.5 2638.6 4335.9
One year change, % -2.0 2.0 11.5 5.5
CAGR 3yr, % 3.8 5.6 5.2 8.2
R&D intensity, % 2.7 5.0 3.2 2.2
Operating Profit, € bn 410.3 530.7 149.3 465.1
One year change, % -6.6 10.6 57.7 9
Profitability9 6.9 13.9 5.7 10.8
Capex, € bn 354.8 232.5 151.2 349.2
One year change, % -0.5 3.0 7.5 4.4
Capex intensity, % 7.1 6.2 6.3 8.9
Employees, million 18.0 11.3 8.3 11.0
One year change, % 0 -3.1 2.7 1.7
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
9 Operating profits as percentage of sales.
Table 1.3  Performance of companies based in the largest countries of the OC (other countries) group.
Factor Switzerland South Korea China Taiwan  OC group
No. of companies 62 80 199 104 676
R&D in 2013, € bn 22.9 19.8 20.3 9.8 96.8
World R&D share 4.2 3.8 7 1.8 18.0
One year change, % 3.6 16.6 9.8 7.5 8.1
CAGR  3yr, % 2.3 9.5 17.0 8.0 9.8
R&D intensity 6.6 2.3 1.5 2.4 2.2
Profitability 15.8 6.7 6.2 5.2 10.8
Employees, thousand 1319.6 8.6 5178.0 416.7 10968.9
One year change, % 0.2 * 2.6 -2.7 1.7
* Many South Korean companies do not report number of employees.
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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1.2.1 Long-term performance of companies by world 
region
The annual growth rates of R&D investment and net sales 
and the profitability of companies based in the EU, the US 
and Japan is provided respectively in figures 1.2, 1.3 and 1.4 
for the period 2005-2013. These figures are based on our 
history database comprising R&D and economic indicators 
over the whole 2005-2013 period (companies: EU 479, US 
636 and Japan 366)10.
The trends observed in these figures show the behaviour 
of these companies including the effects of the crisis that 
began in 2008. The following points are observed:
10 Long term trend data do suffer from survivorship bias since only companies that 
survive in the Scoreboard are analysed in the 2005-2013 period.
• Companies based in the EU broke in 2013 the R&D 
recovery trend observed since 2010. In terms of net sales 
and profitability the EU companies showed a short recovery 
period in 2010-2011 and then weakened again, especially 
regarding the growth rate of net sales over the last period.
• The US companies continued to show R&D investment 
growth similar to the level prior to the crisis but continued 
to show a very low rate of growth of net sales over the 
last two periods. In terms of profitability the US-based 
companies recovered more rapidly from the crisis and 
continued to show a high level of profitability in the last 
period. The profitability of the US companies is higher 
than their EU counterparts and especially higher than the 
Japanese ones.
• Japanese companies, hit hard by the crisis in 2008-2009 
and by the earthquake in 2011, showed impressive figures 
in 2013 in terms of R&D and especially regarding the 
growth rate of net sales. The profitability of Japanese 
companies also recovered in 2013 but remained at low 
levels compared with that of EU and US companies. 
Figure 1.2. One-year R&D investment and net sales growth and profitability by the EU companies.
Note: For 479 out of the top EU 633 companies in the Scoreboard with data for the whole period. Profitability is the ratio of operating profit to net sales. 
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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Figure 1.3. One-year R&D investment and net sales growth and profitability by US companies.
Note: For 636 out of the top US 804 companies in the Scoreboard with data for the whole period.  Profitability is the ratio of net sales to operating profit. 
Source: The 2014 EU Industrial R&D Investment Scoreboard
 European Commission, JRC/DG RTD.
Figure 1.4. One-year R&D investment and net sales growth and profitability by Japanese companies.
Note:  For 366 out of the top Japanese 387 companies in the Scoreboard with data for the whole period.  Profitability is the ratio of net sales to 
operating profit. 
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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1.2.2 R&D trends by world regions and sector groups  
Trends in R&D over the long-term are presented in figure 
1.5 for the main world regions. The figures refer to a set of 
companies that reported R&D over the whole period 2005-
2013 (1994 companies: EU 503, US 681, Japan 374 and rest 
of the world 436). The R&D data are broken down into groups 
of industrial sectors with characteristic R&D intensities (see 
definition in Box 1.1). 
The following points can be observed regarding the overall 
R&D changes in the period 2005-2013 (figure 1.6): 
• The world 1994 companies increased R&D by 52.6% (EU-
503 46.5%; US-681 65.0%; Japan-374 11.8% and other 
countries-436 115.8%).
• For the 503 EU companies, the main R&D increases were 
in low R&D-intensive sectors (84.0%) and medium-high 
sectors (46.5%).   
• For the 681 US companies, the main R&D increases were 
in medium-low R&D-intensive sectors (121.7%) and high 
sectors (77.9%). 
• For the 374 Japanese companies, the main R&D increases 
were in medium-high R&D-intensive sectors (15.7%) and 
high sectors (8.3%). 
• For the 436 companies based in the other countries (OC), 
the main R&D increases were in low R&D-intensive sectors 
(237.2%) and high sectors (117.2%).
• For the EU, the high R&D-intensity group was 40.9% of the 
EU total in 2005, decreasing to 39.2% in 2013 while for 
the US, the share increased from 68.4% in 2005 to 73.7% 
in 2013. 
11 ISIC REV 3. Technology intensity definition, OECD, 7 July, 2011.
Box 1.1. Grouping of industrial sectors according to R&D intensity  (R&D  as % of net sales)*.
High R&D intensity sectors include mainly Pharmaceuticals & biotechnology; Health care equipment & services; 
Technology hardware & equipment; Software & computer services, Aerospace & defence and Leisure Goods.
Medium-high R&D intensity sectors include mainly Electronics & electrical equipment; Automobiles & parts; Industrial 
engineering; Chemicals; Personal goods; Household goods; General industrials; Support services.
Medium-low R&D intensity sectors include mainly Food producers; Beverages; Travel & leisure; Media; Oil equipment; 
Electricity; Fixed line telecommunications.
Low R&D intensity sectors include mainly Oil & gas producers; Industrial metals; Construction & materials; Food & 
drug retailers; Transportation; Mining; Tobacco; Multi-utilities.
* This classification takes into account the R&D intensity of all companies aggregated by ICB 3-digits sectors:  High 
above 5%; Medium-high between 2% and 5%;  Medium-low between 1% and 2% and Low below 1%. Some sectors 
are adjusted to compensate the insufficient representativeness of the Scoreboard in those sectors using the OECD 
definition of technology intensity for manufacturing sectors11. 
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1.2.3 Employment trends by regions and sector groups
In this year’s Scoreboard, 2172 companies out of the 2500 
top R&D investors reported number of employees. The 2172 
companies employed 48.6 million people in 2013, slightly 
more than in 2012 (0.1). The distribution of employees by 
region was 18.0 million in the 603 companies based in the 
EU, 11.3 million in the 765 US companies, 8.3 million in 
the 386 Japanese companies and 11.0 million in the 418 
companies from other countries.  
Trends on employment over the long-term are presented in 
figure 1.6 for the main world regions. The figures refer to a 
set of 1618 companies that reported number of employees 
over the whole period 2005-2013 and are broken down 
into groups of industrial sectors with characteristic R&D 
intensities (see definition in Box 1.1). 
The following points can be observed regarding the changes 
in number of employees in the period 2005-2013 (figure 
1.6): 
• Overall worldwide employment by the 1618 companies 
increased by 23.7% from 2005 to 2013 led by increases 
in high R&D-intensive sectors (35.6%) and medium-high 
sectors (26.6%).
• For the 476 EU companies, the overall employment growth 
was 18.9%, increasing by 40.1% in high R&D-intensive 
sectors and by 25.1% in medium-high sectors.
• For the 525 US companies, the overall employment growth 
(19.1%) greatly varies by sector group: a strong increase 
for high R&D-intensive sectors (34.3%) and a sharp 
decrease in low-tech sectors (-19.9%).
• For the 362 Japanese companies, the overall employment 
increase of 22.1% corresponded to an increase of 33.6% 
in low R&D-intensive sectors and of 26.6% in medium-low 
sectors.
• The ratio of employment in high to medium-high R&D 
intensity sectors for companies based in Japan fell from 
32.3% to 27.2%, rose slightly for EU companies, from 
33.6% to 37.6%, and went up a lot for US companies 
from 99.4% to 122.4%. This illustrates the way high R&D-
intensive sectors in the US have been growing rapidly 
while medium-high sectors such as the automotive sector 
are slowly going down the rankings.
It is important to remember that data reported by the 
Scoreboard companies do not inform about the actual 
geographic distribution of the number of employees. A 
detailed geographic analysis should take into account the 
Figure 1.5  R&D investment trends by the Scoreboard companies for main world regions.
Note: For 1994 out of the 2500 Scoreboard companies with data for the whole period
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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location of subsidiaries of the parent Scoreboard companies 
as well as the location of other production activities involved 
in the value-chains. It is also important to remember that 
innovations by R&D companies in sectors such as software 
and semiconductors can enhance the products and services 
and hence the sales and employment of many companies 
that do not appear in the Scoreboard because they do not 
carry out significant amounts of R&D. Examples are the 
retailing and transport sectors.
Figure 1.6  Employment trends by the Scoreboard companies for main world regions.
Note:  For 1618  out of the 2500 Scoreboard companies with data for the whole period
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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This chapter describes the performance of individual 
companies, with a focus on the results of top R&D investors, 
highlighting those companies that show considerable 
changes in economic performance, in particular from an R&D 
viewpoint.
The world’s top 100 R&D companies are analysed, highlighting 
those presenting important changes from the previous year 
and those showing the best performance in terms of R&D 
and economic growth over the last 10 years. This year’s R&D 
ranking of the top 50 companies is presented in figure 2.1 
and table 2.1 shows changes in such ranking since the first 
Scoreboard in 2004.
Key findings
• The four top R&D investors remain the same as in last 
year’s Scoreboard: Volkswagen from Germany in the 1st 
place, Samsung Electronics from South Korea in the 2nd 
position, and Microsoft and Intel from the US in the 3rd 
and 4th places.  The other companies in the top-ten are 
Novartis and Roche from Switzerland, Toyota from Japan, 
Johnson & Johnson and Google from the US and Daimler 
from Germany.
• The top 100 companies, accounting for 53.1 % of the 
total R&D investment by the 2500 companies, showed 
a significant increase in R&D investment in 2013, but at 
lower pace than that of 2012. Of these 100 companies, 62 
increased R&D investment (vs. 72 in 2012), including 23 
companies with double-digit R&D growth; of the 38 that 
decreased R&D, 7 decreased by a double digit percentage. 
Regarding net sales, 68 companies reported an increase 
(vs. 66 in 2012), including 20 companies with double-digit 
sales growth.
• In the top 100 group, 35.5% of EU companies increased 
R&D compared with about 70% of the US and Japanese 
firms and 92.3% of the other countries. Specifically:
- 31 EU companies of which 11 have increased R&D (5 by 
more than 10%), 
- 39 US companies of which 27 increased R&D (9 by more 
than 10%), 
- 17 from Japan of which 12 increased R&D (3 by more than 
10%) and 
- 13 companies from other countries of which 12 increased 
R&D (6 by more than 10%).
• In the top 100 group, the companies showing the largest 
increase in R&D are Celgene, US (39.0%); Apple, US 
(32.4%); Otsuka, Japan (29.4%); Qualcomm, US (26.9%); 
Samsung Electronics, South Korea (25.4%).  Those showing 
the largest decrease in R&D are Abbot Laboratories, 
US (-66.4% due to demerger); Peugeot (PSA), France 
(-20.8%); STMicroelectronics, The Netherlands (-19.2%); 
Texas Instruments, US (-18.9%), Nokia, Finland (-17.1%). 
Some of the big increases or decreases in R&D may be due 
to acquisitions or demergers (see section 2.2).
• The rapid development of biotechnology is illustrated by 
the performance of the top 4 biotechnology companies, 
all of them based in the US (Celgene, Amgen, Gilead and 
Biogen): they increased R&D by 22.3%, whereas traditional 
pharmaceutical companies decreased it by 1.8%. Gilead 
Sciences, for example, is #68 in this Scoreboard but was 
#318 in 2005 whereas Pfizer was #15 in 2014 but #2 in 
2005.
• Among the top 100 group, 31 companies have at least 
doubled their R&D investment since 2005 (8 companies 
based in the EU and 15 from the US). This group of 
companies is mainly from high R&D-intensive sectors, 23 
of them have increased net sales by more than 100% and 
17 companies increased employment by more than 100%. 
A number of the large increases are for companies that 
have made substantial acquisitions.
2 Top R&D investing companies
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2.1 General trends
In the 2014 Scoreboard 104 companies have an R&D 
investment of more than € 1.0bn (32 from the EU and 40 
from the US) while 53 have R&D exceeding € 2.0bn (17 from 
the EU and 21 from the US).
The top 10 companies each invested more than € 5bn in 
R&D and account for 14.0 % of the total R&D investment by 
the 2500 Scoreboard companies.
The four top R&D investors are the same as in last year’s 
Scoreboard: In the 1st place the German company Volkswagen 
(23.4% R&D increase, up to €11.7bn), from South Korea in 
the 2nd position Samsung Electronics (25.4% R&D increase, 
up to €10.2bn) and from the US in the 3rd and 4th places 
Microsoft (€8.3bn) and Intel (€7.7bn).  The other companies 
in the top-ten are from Switzerland Novartis (€7.2bn) and 
Roche (€7.1bn), from Japan Toyota Motor (€6.3bn), from the 
US Johnson & Johnson (€5.9bn) and Google (€5.7bn) and 
from Germany Daimler (€5.4bn).
The top 100 companies invested € 285.8 billion, accounting 
for 53.1 % of the total R&D investment and 27.0% of the 
total net sales by all the 2500 Scoreboard companies. The 
EU has 31 companies among the top 100 R&D investors, 
three companies more than it had in The 2014 Scoreboard. 
The US has 39 companies, two more than it had last year 
and Japan has 17, five companies less than in last year’s 
Scoreboard.
The EU companies in the top 100 are mainly from the 
Automobiles & Parts (8), Pharmaceuticals & Biotechnology 
(7) and ICT12 sectors (5). The US companies are mainly from 
the ICT (13), Pharmaceuticals & Biotechnology (11), and 
Chemicals (3) sectors. The Japanese companies operate 
mainly in the Automobiles & Parts (4) and Pharmaceuticals 
& Biotechnology (4) sectors.
Sixty-two companies in the top 100 have shown positive 
R&D investment growth. Among them, 23 companies had 
double-digit R&D growth, and of these, 12 companies also 
showed double-digit growth in net sales.  
Most of the top 100 companies showing double-digit R&D 
increases are in the Pharmaceuticals & Biotechnology (6), 
Automobiles & Parts (6) and ICT (4) sectors. The companies 
showing the largest increase in R&D are Celgene, US (39.0%); 
Apple, US (32.4%); Otsuka, Japan (29.4%); Qualcomm, US 
(26.9%); Samsung Electronics, South Korea (25.4%). With the 
exception of Apple, these companies showed also double-
digit growth rate of sales.
Other companies among the top 100 group have shown 
double-digit growth in both R&D and net sales, e.g. Gilead 
12 ICT industries comprise Technology Hardware & Equipment and Software & 
Computer Services sectors.
Sciences and EBay from the US; Honda and Toyota from 
Japan, Taiwan Semiconductor (Taiwan) and Bombardier 
from Canada.
It is interesting to note the different trend of the biotechnology 
versus the standard pharmaceutical companies. The average 
R&D increase of the top 4 biotechnology companies (Celgene, 
Amgen, Gilead and Biogen) was 22.3% whereas that of the 
pharmaceutical companies decreased by 1.8%.
Thirty-seven companies in the top 100 have experienced a 
decrease in R&D investing. Among these, seven companies 
decreased R&D investments and three decreased net 
sales by more than 10 %. The companies with the largest 
decrease in R&D are Abbot Laboratories, US (-66.4% 
because of its demerger); Peugeot (PSA), France (-20.8%); 
STMicroelectronics, The Netherlands (-19.2%); Texas 
Instruments, US (-18.9%), Nokia, Finland (-17.1%).
The R&D intensity of companies in the top 100 (6.3%) has 
increased slightly due to a higher rate of increase for R&D 
(3.7 %) than for net sales (3.2 %). The EU companies in the 
top 100 have a higher average R&D intensity (6.7 %) than 
that of non-EU companies (6.2 %).
2.2 R&D changes driven by 
mergers and acquisitions and 
foreign direct investments
Most of the increases or decreases in company R&D are 
the results of organic growth or of the need to trim costs in 
difficult times. But in some cases big changes in R&D are the 
results of mergers & acquisitions (M&As) or demergers when 
a company sharpens its focus by selling or spinning off one or 
more divisions. Pfizer provides a good example of growth by 
acquisition since it acquired Warner-Lambert in 2000 (giving 
it the super-blockbuster drug Lipitor), Pharmacia for $60bn 
in 2003 and Wyeth for $68bn in 2009. Pfizer then tried but 
failed to take over AstraZeneca earlier this year. The best 
example of a demerger in the Scoreboard is Abbott/AbbVie. 
Abbott Laboratories demerged its pharmaceutical division 
into a separate company now called AbbVie whose shares 
were listed in December 2012. AbbVie now has a market cap 
larger than that of Abbott, its former owner. The result of 
the demerger is that AbbVie is in the 52nd place in this year’s 
Scoreboard whereas Abbott is at the 95th place (in last year’s 
Scoreboard Abbott was at the 35th place). This illustrates the 
big effect that a demerger can have on R&D and company’s 
position in the Scoreboard. A similar demerger but on a 
much smaller scale is Elan’s demerger of its drug discovery 
activities as a separate company Prothena. A number of 
other companies have announced that they are planning 
demergers – these include HP and eBay/PayPal. 
Some facts and figures concerning M&As and foreign direct 
investments (FDIs) over the past 7 years for the top 50 R&D 
investors are provided in table 2.1. The table reports the 
2  T o p  R & D  i n v e s t i n g  c o m p a n i e s
33
total value of M&A deals per company, the number of M&As, 
the total value of investment and corresponding number of 
greenfield FDI projects and number of domestic and cross 
border M&As. Although not available for all world top 50 
R&D investors, the values of M&As are on average larger 
than those of greenfield FDI.
Table 2.1.  Foreign investment activities involving the top 50 Scoreboard companies over the past 7 years. 
Company name
Tot value of 
M&A deals 
-€bn
N. of 
deals
Tot value of FDI 
(from 2003) 
-€bn
N. of FDI 
projects
Domestic 
M&A
Cross 
border 
M&A
PFIZER 49.23 17 3.50 85 13 4
MERCK US 39.62 4 3.58 61 3 1
ORACLE 22.09 29 1.26 101 25 4
SANOFI-AVENTIS 18.10 11 3.03 73 1 10
GOOGLE 17.63 105 5.25 128 77 28
HEWLETT-PACKARD 17.09 22 7.90 272 16 6
GENERAL ELECTRIC 17.02 24 22.79 399 12 12
JOHNSON & JOHNSON 16.81 8 2.83 77 7 1
MICROSOFT 16.79 44 8.49 283 29 15
ASTRAZENECA 16.13 10 1.42 40 1 9
CISCO SYSTEMS 15.95 47 5.70 109 38 9
SIEMENS 13.22 26 16.09 415 5 21
BAYER 11.97 3 6.33 175 3 0
IBM 11.27 72 11.40 521 52 20
BRISTOL-MYERS SQUIBB 10.94 7 0.68 20 7 0
AMGEN 10.41 8 1.05 18 6 2
PANASONIC 10.12 11 5.31 158 8 3
VOLKSWAGEN 10.01 6 50.02 364 5 1
TAKEDA 
PHARMACEUTICAL 9.60 1 0.72 33 0 1
ELI LILLY 8.40 8 2.95 33 7 1
GLAXOSMITHKLINE 7.62 9 4.26 102 2 7
INTEL 7.16 28 16.20 159 13 15
NOKIA 6.97 17 3.48 144 3 14
SAP 5.47 21 1.74 114 4 17
ERICSSON 4.40 22 2.77 99 0 22
APPLE 4.04 30 0.29 19 22 8
HITACHI 3.76 18 10.44 210 13 5
QUALCOMM 2.79 17 2.16 35 8 9
GENERAL MOTORS 2.57 2 36.67 251 1 1
SONY 2.28 5 8.58 125 3 2
ROBERT BOSCH 1.77 19 8.83 252 10 9
EMC 1.75 23 1.71 78 17 6
TOSHIBA 1.28 13 4.70 126 3 10
TOYOTA MOTOR 1.25 5 34.32 462 3 2
DENSO 1.15 3 2.50 90 2 1
SAMSUNG ELECTRONICS 0.94 11 19.20 88 5 6
FIAT 0.56 6 27.89 193 3 3
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HUAWEI 0.42 3 4.49 155 1 2
DAIMLER 0.28 11 17.65 133 8 3
LG ELECTRONICS 0.15 1 3.87 101 1 0
FORD MOTOR 0.15 4 30.49 182 3 1
NISSAN MOTOR 0.13 6 2.90 18 0 6
ALCATEL-LUCENT 0.01 2 1.67 37 1 1
AIRBUS n.a. 6 9.71 205 1 5
HONDA MOTOR n.a. 1 2.37 22 1 0
BMW 10.15 117
BOEHRINGER INGELHEIM 1.51 37
NOVARTIS 7.20 101
ROCHE 3.59 66
VOLVO 8.03 165
Total 399.49 748 2224 7255 443 305
Source : Zephir database by Bureau van Dijk and fDi Markets database by the Financial Times
2.3 Long-term performance of 
top R&D companies
This section analyses the behaviour of the top companies 
over the last 10 years based on our history database 
containing company data for the period 2002-2013.  Results 
of companies showing outstanding R&D and economic 
results are underlined. 
Ranking of the top 50
Figure 2.1 shows the ranking of the top 50 global R&D 
companies with their 2010 rank shown in brackets. Table 
2.2 then shows main R&D data and the evolution of the R&D 
rankings of the top 50 companies since the first Scoreboard 
in 2004 and the most important changes are highlighted. 
It is important to note, as stated in the previous section 
and in past reports, that the growth of companies is often 
accompanied by mergers and acquisitions while decreases 
may be the result of demergers. 
There are 17 EU companies (18 in 2004) and 33 non-EU 
companies (32 in 2004). 
In the EU group, four companies left the top 50 (Philips, 
Renault, BAE Systems and Peugeot) and three companies 
joined the top 50 (Boehringer Ingelheim, Volvo and SAP).
In the non-EU group, eight companies left the top 50 (Fujitsu, 
Matsushita Electric, NEC, Motorola, Nortel Networks, Wyeth, 
Delphi, Sun Microsystems) and nine companies joined the top 
50 (Amgen, Apple, Denso, Google, Huawei, Oracle, Panasonic, 
Qualcomm and Takeda Pharmaceuticals).
The distribution of the top 50 companies by main industrial 
sector and region changed from 2004 to 2013 as follows:
• Automobiles & Parts, from 13 (EU 7) to 11 (EU 5)
• ICT industries, from 15 (EU 3) to 15 (EU 4)
• Pharma & Biotech, from 11 (EU 3) to 14 (EU 5)
The EU companies that improved by at least 20 places are 
Boehringer Ingelheim (now ranked 39st), Sanofi (now 14th), 
SAP (now 46th) and Volvo (now 50th).  
There are 9 non-EU companies that gained more than 20 
places. They include Google, up 173 (now 9th), Qualcomm, up 
112 (now 25th), Huawei, up more than 200 (now 26st), Oracle, 
up 47 (now 24th). 
Three companies dropped twenty or more places but 
remained within the top 50: Sony (now 36th) and Hewlett 
Packard (now 47th).
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Figure 2.1.  The world’s top 50 companies by their total R&D investment (€m) in the 2014 Scoreboard.
Note: The number in brackets after the name of the company indicates the ranking in 2010.
Source: The 2014 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
T h e  2 0 1 4  E U  I n d u s t r i a l  R & D  I n v e s t m e n t  S c o r e b o a r d
36
Table 2.2. The top 50 companies in the 2014 Scoreboard: R&D data and rank change 2004- 2014. 
Rank in 
2014 Company Country
R&D in 2013 
(€m)
R&D intensity 
(%)
Rank change 
2004- 2014
1 VOLKSWAGEN Germany 11743.0 6.0 up 7
2 SAMSUNG ELECTRONICS South Korea 10154.9 6.5 up 31
3 MICROSOFT US 8252.5 13.1 up 10
4 INTEL US 7694.1 20.1 up 10
5 NOVARTIS Switzerland 7173.5 17.1 up 15
6 ROCHE Switzerland 7076.2 18.6 up 12
7 TOYOTA MOTOR Japan 6269.9 3.5 down 2
8 JOHNSON & JOHNSON US 5933.6 11.5 up 4
9 GOOGLE US 5735.6 13.2 up 173
10 DAIMLER Germany 5379.0 4.6 down 7
11 GENERAL MOTORS US 5220.8 4.6 down 5
12 MERCK US US 5165.0 16.2 up 17
13 BMW Germany 4792.0 6.3 up 15
14 SANOFI- AVENTIS France 4757.0 14.4 up 8
15 PFIZER US 4750.2 12.7 down 13
16 ROBERT BOSCH Germany 4653.0 10.1 up 10
17 FORD MOTOR US 4640.7 4.4 down 16
18 CISCO SYSTEMS US 4563.8 13.4 up 13
19 SIEMENS Germany 4556.0 6.0 down 15
20 HONDA MOTOR Japan 4366.7 5.4 down 4
21 GLAXOSMITHKLINE UK 4154.3 13.1 down 10
22 IBM US 4088.9 5.7 down 13
23 ELI LILLY US 4010.8 23.9 up 18
24 ORACLE US 3735.0 13.5 up 47
25 QUALCOMM US 3601.6 20.0 up 112
26 HUAWEI China 3589.3 25.6 up > 200
27 AIRBUS The Netherlands 3581.0 6.0 up 8
28 ERICSSON Sweden 3484.8 13.6 down 11
29 NOKIA Finland 3456.0 14.7 down 19
30 NISSAN MOTOR Japan 3447.2 4.8 up 4
31 GENERAL ELECTRIC US 3444.3 3.3 up 6
32 FIAT Italy 3362.0 3.9 up 12
33 PANASONIC Japan 3297.2 6.2 down 26
34 BAYER Germany 3259.0 8.1 down 2
35 APPLE US 3244.9 2.6 up 120
36 SONY Japan 3209.1 21.3 down 21
37 ASTRAZENECA UK 3202.8 17.2 down 12
38 AMGEN US 2960.6 21.9 up 18
39 BOEHRINGER INGELHEIM Germany 2743.0 19.5 up 23
40 BRISTOL- MYERS SQUIBB US 2705.4 22.8 up 2
41 DENSO Japan 2538.9 9.0 up 12
42 HITACHI Japan 2420.0 3.7 down 18
43 ALCATEL- LUCENT France 2374.0 16.4 up 4
44 EMC US 2355.2 14.0 up 48
45 TAKEDA PHARMACEUTICAL Japan 2352.0 20.2 up 28
46 SAP Germany 2282.0 13.6 up 23
47 HEWLETT- PACKARD US 2273.2 2.8 down 24
48 TOSHIBA Japan 2269.1 5.1 down 18
49 LG ELECTRONICS South Korea 2208.5 5.5 up 61
50 VOLVO Sweden 2130.5 6.9 up 27
Note : Companies in "blue" went up more than 20 ranks and in "red" lost more than 20 ranks.
Source:  The EU Industrial R&D Investment Scoreboards 2014 and 2004. 
European Commission, JRC/DG RTD.
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Best performers among the top 100
Among the top 100 group, 31 companies have at least 
doubled their R&D investment since 2005 (8 companies 
based in the EU and 15 from the US). This group of top 100 
companies is mainly from high R&D-intensive sectors, 23 
of them have increased net sales by more than 100% and 
17 companies increased employment by more than 100%. A 
number of the large increases are for companies that have 
made substantial acquisitions. 
The table 2.3 presents the list of 12 companies that 
increased simultaneously R&D, net sales and employment 
by more than 100% over the 2005-2013 period. Ten out of 
these companies are based in the US and operate in ICT and 
biotech industries. This illustrates the specialisation of US 
companies in high R&D-intensity sectors and their growing 
dominance observed over the past ten years (see chapter 4). 
Table 2.3.  Companies among the top 100 R&D investors that achieved the best performance from 2005 to 
2013* (ranked by R&D in 2013). 
World 
rank Company Country Sector
R&D in 2013
(€ m)
9 GOOGLE US Software & Computer Services 5735.6
24 ORACLE US Software & Computer Services 3735.0
25 QUALCOMM US Technology Hardware & Equipment 3601.6
35 APPLE US Technology Hardware & Equipment 3244.9
44 EMC US Technology Hardware & Equipment 2355.2
55 CONTINENTAL Germany Automobiles & Parts 1918.6
59 BROADCOM US Technology Hardware & Equipment 1802.6
65 CELGENE US Pharmaceuticals & Biotechnology 1603.4
68 GILEAD SCIENCES US Pharmaceuticals & Biotechnology 1537.1
71 EBAY US General Retailers 1498.8
82 WESTERN DIGITAL US Technology Hardware & Equipment 1204.4
100
TEVA 
PHARMACEUTICAL 
INDUSTRIES
Israel Pharmaceuticals & Biotechnology 1031.1
* These companies increased simultaneously R&D investment, net sales and employment by more than 100 % from 2005 to 2013 and had positive 
operating profits in 2013.
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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This chapter presents an analysis of the technological profiles 
of the Scoreboard companies based on the examination of 
their patent portfolios. The focus is on the technological 
development of the top 100 R&D investors, addressing 
the following questions: In which technological fields do 
they specialise? What is their degree of specialisation or 
diversification? What is their involvement in developing 
key technologies expected to produce major societal 
changes? How do they compare with respect to their sector 
counterparts? 
In some cases the field of specialisation and the sector are 
less easy to define since a company may have substantial 
businesses in two or more sectors or subsectors.
Key findings
• In 2010-2012, the 2000 Scoreboard companies have filed 
about one third of the total patents at the EPO and USPTO 
offices. The top 100 R&D investors have filed 53.2% of the 
overall Scoreboard patents.   
• The patent propensity of companies (patents to R&D ratio) 
is very much sector-specific. The Electronic and Electrical 
Equipment sector shows the highest patent propensity, 
about ten times larger than that of the Pharmaceuticals 
& Biotechnology sector.  The average patent propensity of 
the top 100 R&D investors is similar to that of the 2000 
sample.
• The three most patented technologies by company give an 
indication of its degree of specialisation or diversification. 
The results show a great variety across sectors and 
companies. The largest specialisation is shown by the 
Technology Hardware & Equipment and the Pharmaceutical 
& Biotechnology sectors.         
• Patent activity related with key enabling technologies 
differs also greatly across industries. In general, Chemicals, 
Electronic & Electrical Equipment, General Industrial and 
Pharmaceutical & Biotechnology sectors appear to be 
the most KETs intensive, but large differences between 
companies are also observed.
3.1 Overview
Matching company and patent data allows the identification 
of the technological fields in which the Scoreboard companies 
are involved. Patent data have been built up, in collaboration 
with the OECD,13 using the information on the ownership 
structure of the 2000 companies in The 2014 Scoreboard, 
and considering those patents filed at the EPO and USPTO 
patent offices over the period 2010-2012. In order to control 
for the multiple filing of the same invention, different patent 
applications have been matched through INPADOC families14 
to avoid double counting.
The technological classification proposed by Schmoch15 is 
applied in order to simplify the interpretation of the patent 
data. This classification groups the patents (IPC classes) into 
35 technological fields belonging to five technological areas, 
namely: Electrical Engineering, Mechanical Engineering, 
Instruments, Chemistry, and Other Fields. In a second 
step, patents related to key enabling technologies (KETs)16 
have been identified to have a look to the activity of the 
Scoreboard companies in those technologies. KETs are 
identified according to the following partition: industrial 
biotechnology, nanotechnology, micro- and nano-electronics, 
photonics, advanced materials, and advanced manufacturing 
technologies.
Over the period considered, the top 2000 Scoreboard 
companies have filed about 30% and 33% of the total 
patents, at EPO and USPTO offices respectively.
13 The JRC-IPTS of the European Commission and the Directorate for Science, 
Technology and Innovation of the OECD are currently collaborating to analyse the 
patent and trademark portfolios of the EU R&D Scoreboard companies. The results will 
be presented in a joint report to be published in the first half of 2015.   
14 See definition at: http://www.epo.org/searching/essentials/patent-families/inpadoc.
html
15 See the concept note at: http://www.wipo.int/export/sites/www/ipstats/en/statistics/
patents/pdf/wipo_ipc_technology.pdf. For an up-to-date concordance table, see: http://
www.wipo.int/ipstats/en/statistics/technology_concordance.html.
16 The classification could be find in: “Feasibility study for an EU Monitoring Mechanism 
on Key Enabling Technologies” (2012)
3  Technological specialisation of 
companies
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3.2 Patents vs R&D investment 
by sector
This section presents the ratio of number of patents to R&D 
investment, defined as the propensity to patent17, for the top 
2000 R&D investors included in The 2014 Scoreboard. This 
indicator describes the relationship between patents and 
innovative efforts, and allows sector comparisons.  
Figure 3.1 reports the patent propensity of the top 2000 
investors of The 2014 Scoreboard, calculated as the 
sector’s average number of patents per million euro of R&D 
investment over the period 2010-2012.
The figure shows that the patent propensity varies greatly 
across sectors ranging from about 0.01 for Banking to the 
0.67 of the Electronic and Electrical equipment sector.
17 Scherer, F.M. “The propensity to patent.” International Journal of Industrial 
Organization 1.1 (1983): 107-128.
The highest patent propensities are shown by the Electrical 
Equipment, Leisure Goods, and General Industrial sectors, all 
with values above 0.6 (meaning an average R&D investment 
of €1.7 million per patent family). 
Household Goods & Home Construction, Health Care 
Equipment & Services, Chemicals, Technology Hardware 
& Equipment represent a second grouping of sectors that 
display values ranging from 0.41 and 0.52. 
Apart from the Software and Computer Services sector (0.36) 
all the other sectors present values for patent propensity 
below 0.3. The Pharmaceuticals & Biotechnology sector 
presents the second lowest value for the patent/R&D ratio. 
This is due, at least in part, by the substantial investments 
required to guarantee that a compound is effective, safe and 
admissible by the regulatory agencies.    
Figure 3.1. Patent propensity of the 2014 Scoreboard companies by main industry.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
Note: Sectors with at least 20 companies are reported. Calculations based on the Worldwide Patent Statistical Database, EPO, Spring 2014 and The 
2014 EU Industrial R&D Investment Scoreboard.
Number of patents/€m
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It should be noted that a higher patent propensity does not 
imply a better performance. In fact, the number of patents 
per se does not necessarily indicate the technological and 
economic value of the patent portfolio. This is an issue that 
deserves further investigation, including a deeper analysis 
of the technologies involved and their impact on the value 
chain of the company. 
3.3 Patent activity of the top 
100 R&D investors
The top 100 R&D investors have filed 53.2% of the overall 
Scoreboard patents, with a patent propensity very close to 
that recorded for the whole sample. 
The Table 3.1 summarises the most important patent data 
on the top 100 R&D investors of The 2014 Scoreboard. 
Specifically, the table reports for each company the total 
number of patents from 2010 to 2012, the shares of the 
three most patented technological fields, the share of these 
three fields (as a measure of technological specialisation 
vs diversification), and finally, the share of patents with 
at least one technology related to KETs. Companies are 
grouped according to the ICB sector in which they operate 
and ranked by R&D.
The technological specialisation (concentration) of the 
Pharmaceutical & Biotechnology, Technology Hardware 
& Equipment and Software and Computer service sectors 
appears to be, in general, higher than that of the other 
sectors reported in the table (blue bars). 
The sector classification is also useful to identify the 
most important technologies for Pharmaceuticals & 
Biotechnology and Automobiles & Part companies, most 
of them share the same technology as the core of their 
innovation activity. However, marked differences arise 
across companies operating in the same sector. 
In the Pharmaceutical & Biotechnology sector, some 
companies appear to be more specialized in medical 
technologies (Johnson & Johnson, Sanofi-Avensis and 
Abbott Laboratories), Bayer is particularly active in basic 
material chemistry and Merck DE in organic chemistry. 
Merck DE appears to be the most diversified company 
of this group, it presents similar shares for the top three 
technologies, and their sum is below 50% of the total 
patents. Biotechnology does not still represent the first 
technology of any of the companies considered, but Novo 
Nordisk (31%), Amgen (30%) and Roche (20%) have an 
important share of their patents related to biotechnologies. 
Among the three most represented sectors in the top 100 
group, the Technology Hardware and Equipment sector 
presents the highest variety of top technologies developed. 
Digital communication and computer technologies are 
in general the two most important technologies of this 
group of companies, but semiconductors, audio-visual 
technologies and optics represent an important share 
of the technology base for some companies, e.g. Texas 
Instrument, Western Digital, STMicroelectronics and Canon.
Companies operating in the Automobiles & Parts sector 
present medium-low values of technological concentration 
(Nissan scoring the highest one, 72%).  Transport is the 
core technology of this sector group, with only Robert Bosch 
and Denso (both are parts companies) having Electrical 
Machinery and apparatus as the most relevant technology.
Similar to those in the Automobiles & Parts sector, 
companies grouped under the Electronic and Electrical 
Equipment sector present a medium-low degree of 
concentration, but very different technological profiles. In 
terms of top technologies, Samsung present a remarkable 
high number of patents and a low concentration of 
technological base.  
The involvement of companies in KETs related inventions 
(3rd column of Table 3.1) varies greatly across industries. 
Overall, Chemicals, Electronic and Electrical Equipment, 
General Industrial and the Pharmaceutical & Biotechnology 
sectors appears to be the most KETs intensive, but with 
large differences across companies. On the other hand 
companies operating the Automobiles & Parts and 
Technological Hardware and Equipment sectors present a 
low degree of KETs related technologies. However, some 
companies stand out with respect to their counterparts: 
STMicroelectronics (34%) and Texas Instrument (33%) in 
the former and Fiat (22%) in the latter.  
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Table 3.1. The technological profiles of the top 100 
Scoreboard companies.
Table 3.1. The technological profiles of the top 100 Scoreboard companies.
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Note: ‘Share of KETs patents’ is calculated as the number of patents with at least one IPC code classified as KET over the total patent portfolio of a 
company. ‘Tech. Spec.’ is the share of the top three technologies of a company. 
Source: Calculations based on the Worldwide Patent Statistical Database, EPO, Spring 2014 and The 2014 EU Industrial R&D Investment Scoreboard.
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3.4 Focus on patent propensity 
of most relevant sectors 
This section presents the patent propensity of the companies 
operating in the three most represented industries of the 
top 100 R&D investors: Pharmaceuticals & Biotech (22), 
Technological Hardware (17), Automobile & Parts (16 
companies). 
As mentioned above, patent propensity varies greatly 
across industries; however, there are also considerable firm 
differences within the sectors. Figure 3.2 reports the average 
number of patents filed yearly during the period 2010-2012 
versus the average R&D investment for the same period. A 
regression line is reported together with R&D and patent 
figures.
Some companies lie notably far from the best fit line, those 
above having higher number of patents than sector’s average 
and the contrary for those below.
Figure 3.2 reports these figures for the Pharmaceuticals 
& Biotechnology sector. In this sector Abbot Laboratories, 
Bayer, Johnson & Johnson, Merck De, Roche and Sanofi-
Aventis, show the highest patent to R&D ratio. However, most 
of these companies have significant operation in different 
subsectors. In particular Abbot Laboratories is now focused 
on health care after demerging its pharmaceutical division 
to form a new company, AbbVie; Bayer is particular active 
in chemicals, Johnson & Johnson in health care, Merck De in 
chemicals and life-science tools, and Roche is the top world 
company in diagnostics. Therefore, the reported best fit line 
in figure 3.1 excludes these companies which are shown in 
red.
Figure 3.2 Pharmaceutical & Biotechnology, patent propensity of top R&D investors.
Source: Calculations based on the Worldwide Patent Statistical Database, EPO, Spring 2014 and the EU Industrial R&D Investment Scoreboard.
Note: Companies with red markers have not been included for the calculation of the best fit line.
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In the Technological Hardware and Equipment sector, 
companies’ differences in patent propensity are even more 
significant. Apart from Canon, Qualcomm and Research in 
Motion, companies file a similar number of patents with very 
different R&D investments.  This is due to the great variety 
of the technological profiles in this sector as presented in 
table 3.1.
ICT technologies have experienced sustained growth rates 
in the past decades and are subject to a rapid evolution. 
Companies operating in this sector show a high variety of 
technological profiles and do not constitute a homogeneous 
group. More refined analyses on their technological profiles 
could help in building homogeneous typologies of firms able 
to better describe ICTs. 
Figure 3.3   Technology Hardware & Equipment, patent propensity of top R&D investors.
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Note: Given the high variety of technological specialization, the best fit line is not included.
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Finally, in the Automobiles and Parts sector Robert Bosch, 
Denso and General Motors have the highest patent to R&D 
ratio. However, this sector is made of two substantially 
different sub-sectors: vehicles and components. In Figure 
3.4, the two types of companies are distinguished, the 
component companies in red and those mainly producing 
vehicles in blue. 
The best fit line for the component companies is steeper 
than that of vehicles producers, companies operating in 
this sub-sector show a higher patent propensity. As noted 
before, Robert Bosch and Denso are the only two companies 
having the development of electrical machinery apparatus 
rather than transport technologies as the most prominent 
technological field.
Figure 3.4  Automobiles & Parts, patent propensity of top R&D investors.
Source: Calculations based on the Worldwide Patent Statistical Database, EPO, Spring 2014 and the EU Industrial R&D Investment Scoreboard.
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This chapter presents the main R&D trends among the 2014 
Scoreboard companies aggregated by industrial sectors18. 
It comprises the ranking of sectors by their level of R&D 
investment, R&D intensities, rates of R&D growth and the 
comparison of such trends across world regions. 
Key findings
• Companies from the top two R&D investing sectors 
achieved a modest increase of R&D, Pharmaceuticals 
& Biotechnology (2.4%) and Technology Hardware & 
Equipment (3.3%). The following three top sectors increased 
R&D well above the world average of 4.9%:  Software 
& Computer Services (11.4%), Electronic & Electrical 
Equipment (9.0%) and Automobiles & Parts (7.1%).  The 
highest R&D growth was showed by the Construction & 
Materials sector (13.6%) which is, however, a small sector 
in R&D terms.
• In the Pharmaceuticals & Biotechnology sector, companies 
operating in biotechnology increased R&D by 20.4% 
whereas the traditional pharmaceutical companies 
decreased it by 0.2%.  As observed in chapter 2, this is 
mostly due to the rapid development of biotechnology, 
illustrated by an outstanding performance of the top 
biotechnology companies based in the US (Celgene, 
Amgen, Gilead, Biogen and Regeneron).
• Among the top 5 sectors, companies based in the EU had 
the highest R&D growth in Software & Computer Services 
(7.9%) and Automobile & Parts (6.2%). The highest 
R&D growth in the EU was showed by the Fixed Line 
Telecommunications sector (8.6%). 
• Trends observed in the Scoreboard over the last 10 years 
show a characteristic industrial specialisation of the 
EU and US companies that persists after the crisis and 
appears to have been reinforced over the past few years: 
Concentration of the EU companies in medium-high R&D 
intensity sectors, in particular in Automobiles & Parts with 
18 According to the Industry Classification Benchmark (ICB) applied in the Scoreboard.
total domestic and sector world R&D shares of 25.6% and 
49.6% respectively; and US companies dominating in high 
R&D-intensity sectors, particularly in ICT industries with 
total domestic and sector world R&D share of 44.5% and 
62.7% respectively.  
4.1 General R&D trends
Figure 4.1 shows the R&D rankings of companies from the 
main industrial sectors including the relative R&D share 
by main world region. The specialisation of the main world 
regions, represented by the share of sectors within the 
regions’ total R&D investment, is given in figure 4.2.
• R&D investment in the Scoreboard remains highly 
concentrated by sectors: Out of 40 industrial sectors, the 
top three –Pharmaceuticals & Biotechnology, Technology 
Hardware & Equipment and Automobiles & Parts– account 
for 49.6% of the total R&D investment by the Scoreboard 
companies; the top 6 and top 15 sectors constitute, 
respectively, 71.1% and 92.1% of the total R&D in the 
Scoreboard. A similar concentration of R&D in a relatively 
small number of industrial sectors has been observed over 
the last 10 years.
• The ranking of the top 15 sectors has changed as follows: 
The Banks sector took over the 13th position from the Fixed 
Line Telecom (now 14th) and the Construction & Materials 
sector took the 15th position from Food Producers (now 
16th).
• The Pharmaceuticals & Biotechnology sector keeps the 
first position in the R&D ranking, keeping a similar share 
of the total R&D investment (18.0%). It is followed by the 
Technology Hardware & Equipment sector with a share 
of R&D 16.1% (slightly lower to last year’s 16.4%) and 
the Automobile & Parts sector with 15.5%, slightly similar 
than the 15.7% of last year.
• The R&D specialisation (share of R&D investment) of the 
main regions in the top 3 sectors are: 
4 R&D distribution by industrial 
sector
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In the EU, Automobiles & Parts (25.6%), Pharmaceuticals 
& Biotechnology (17.3%), and Technology Hardware & 
Equipment (9.2%); 
In the US, Technology Hardware & Equipment (24.8%), 
Pharmaceuticals & Biotechnology (21.4%) and Software & 
Computer Services (19.7%);
 In Japan, Automobiles & Parts (27.6%), Electronic & Electrical 
Equipment (13.0%) and Pharmaceuticals & Biotechnology 
(11.1%). 
The contribution to the total Scoreboard  R&D by EU companies 
is 51.6% to Aerospace & Defence, 49.6% to Automobiles & 
Parts and 40.4% to the Industrial Engineering sectors; the 
US contributes 75.0% to Software and Computer Services, 
63.7% to Health Care Equipment & Services and 55.6% to 
Technology Hardware & Equipment and; Japan contributes 
30.4% to General Industrials, 29.5% to Chemicals, 26.8% 
to the Electronic & Electric Equipment sector and 28.2% to 
Automobiles & Parts.
4.2 R&D growth by industrial 
sector
The actual contribution of an industrial sector to the overall 
R&D growth of a region depends on its rate of R&D change 
and the sector’s share of total R&D of the region. Figures 4.1 
and 4.2 show the shares of the main industrial sectors and 
table 4.1 shows their ranking by R&D annual growth rate 
worldwide for the Scoreboard companies based in the main 
world regions (EU-633, US-804, and Japan-387).
The following points are observed for the top 15 sectors 
accounting for 92.1% of the total R&D investment of the 
Scoreboard companies:
• Worldwide, the Construction & Materials sector shows 
the highest one-year growth rate (13.6%) followed by 
Software & Computer Services (11.4%), Electronic & 
Electric Equipment (9.0%), and Automobiles & Parts (7.1%) 
sectors. The significant R&D growth rate of the Electronic 
& Electric Equipment sector is due to a large extent by the 
R&D growth of Samsung Electronics (25.4%) that accounts 
for one quarter of the total R&D of the sector worldwide.
• Among the companies based in the EU, the Fixed Line 
Telecom sector shows the highest one-year growth rate 
(8.6%), followed by the Software & Computer Services 
(7.9%). The sectors showing the lowest one-year R&D 
growth are Technology Hardware & Equipment (-5.4%) 
and Industrial Engineering (0.9%).  The low R&D growth 
rate of the Industrial Engineering sector is mostly due to 
the R&D decrease of Volvo (-6.5%), company that accounts 
for 22.4% of the total sector R&D of the EU-633 sample. 
• Among the companies based in the US, the Fixed Line 
Telecom sector shows the highest one-year growth rate 
(17.5%) followed by Software & Computer Services 
(12.0%) and Oil & gas Producers (7.6%). Sectors showing 
the lowest one-year R&D growth are Industrial Engineering 
(-6.4%) and Aerospace and defence (-0.9%). 
• For Japanese companies, the highest one-year growth 
rate is shown by Automobiles & Parts (11.0%) and 
Pharmaceuticals & Biotechnology (9.3%). The poorest 
performance was shown by Fixed Line Telecom (-7.4%) 
and Oil & Gas Producers (-6.7%).
Apart from the top 15 industries, there were important R&D 
changes in some other sectors:
• Most services sectors (financing, insurance, leisure, 
travelling) showed double-digit R&D growth.
• The alternative energy sub-sector that has shown a 
substantial increase of R&D investment before the crisis, 
continued to decrease R&D investment in 2013 (-1.9%) 
following the sharp R&D reduction in 2012 (-22.9%).
• The Industrial Transportation sector reduced considerably 
its R&D investment (-14.2%).
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Figure 4.1.  R&D ranking of industrial sectors and share of main world regions for the world’s top 2500 
companies.
Source: The 2014 EU Industrial R&D Investment Scoreboard
 European Commission, JRC/DG RTD.
Figure 4.2. R&D shares of sectors of the main world regions.
Source: The 2014 EU Industrial R&D Investment Scoreboard
 European Commission, JRC/DG RTD.
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Table 4.1.   Ranking of top 15 industrial sectors by overall one-year R&D growth for the EU, US and Japanese 
companies in the 2014 Scoreboard.
Rank Sector
Overall 
one-
year 
R&D 
growth 
(%)
EU-633
R&D change (%)
1 year       3 years 
US-804
R&D change (%)
1 year    3 years   
Japan-387 
R&D change (%)
1 year      3 years  
1 Construction & Materials 13.6 1.3 5.2 5.3 4.7 7.0 3.2
2
Software & Computer 
Services
11.4 7.9 11.9 12.0 11.6 -4.0 -3.6
3
Electronic & Electrical 
Equipment
9.0 5.4 5.4 1.8 6.5 1.7 -0.5
4 Automobiles & Parts 7.1 6.2 11.6 5.6 5.2 11.0 8.6
5 Banks 4.9 5.6 8.4         
6
Health Care Equipment & 
Services
4.8 5.2 9.4 3.5 5.9 8.2 3.6
7
Fixed Line 
Telecommunications
4.8 8.6 -0.1 17.5 6.0 -7.4 -2.4
8 General Industrials 4.6 2.7 5.8 3.6 5.1 7.6 3.1
9 Oil & Gas Producers 4.6 6.7 6.0 7.6 4.5 -6.7 -2.8
10 Aerospace & Defence 4.2 3.8 6.1 -0.9 -0.3 9.3 11.3
11 Chemicals 4.2 3.1 7.2 2.8 5.7 3.7 2.1
12
Technology Hardware & 
Equipment
3.3 -5.4 -1.8 6.5 9.9 0.5 -0.1
13 Leisure Goods 3.0 6.7 4.1 3.1 1.3 -0.8 0.7
14
Pharmaceuticals & 
Biotechnology
2.4 0.9 2.8 0.4 2.5 9.3 3.0
15 Industrial Engineering 0.1 0.9 7.9 -6.4 6.7 7.3 4.8
Total 40 industries 4.9 2.6 5.8 5.0 7.0 5.5 3.0
Source:   The 2014 EU Industrial R&D Investment Scoreboard.
               European Commission, JRC/DG RTD
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4.3 R&D intensity by sector
Table 4.2 provides the list of industrial sectors ranked by 
worldwide R&D intensity of the main industrial sectors for 
the 2500 Scoreboard companies grouped by main world 
region. 
The following points are observed:
• Some industrial sectors increased their R&D intensity as 
R&D investment increased more than net sales in 2013, 
in particular the Software & Computer Services (11.4% vs. 
7.2%) and Technology Hardware & Equipment (3.3% vs. 
2.2%). The opposite happened for Health Care Equipment 
& Services (4.8% vs 7.0%) and Industrial Engineering 
(0.1% vs 1.4%). 
• Four sectors have an R&D intensity of more than 5.0%: 
Pharmaceuticals & Biotechnology, IT sectors (Software 
& Computer Services and Technology Hardware & 
Equipment) and Leisure Goods (mainly electronic leisure). 
The sector with the lowest R&D intensity is Oil & Gas 
Producers (0.3%). 
• Among the top 15 sectors, the R&D intensity of EU 
companies is larger than that of the US and Japan in 6 
sectors (Electronic & Electrical Equipment, Technology 
Hardware & Equipment, Industrial Engineering, General 
Industrials, Automobiles & Parts and Aerospace & 
Defence). Japanese companies show higher R&D intensity 
than the EU and the US in sectors such as Leisure Goods 
and Chemicals. The R&D intensity of US companies is 
higher than that of the EU and Japan in Pharmaceuticals 
& Biotechnology and Software & Computer Services.
• As observed in previous Scoreboards, the overall lower 
average of R&D intensity of the EU companies is due to 
their large share of low R&D-intensive sectors with very 
large sales such as Oil & Gas, Mining, Banks, as compared 
to a similar group of non-EU companies. Conversely, the 
high average  R&D intensity of the US companies is due 
to their considerable weight in high R&D-intensive sectors 
(see Figures 4.1 and 4.2)
Table 4.2.  Ranking of the top 15 industrial sectors by overall R&D intensity for the EU, US and  Japanese 
companies in the 2014 Scoreboard.
Rank Sector
Overall sector 
R&D intensity, 
%
EU-633 
sector R&D 
intensity, %
US-804
sector R&D 
intensity, %
Japan-387 
sector R&D 
intensity, %
1
Pharmaceuticals & 
Biotechnology
14.4 13.3 16.3 14.6
2
Software & Computer 
Services
10.4 10.5 12.3 4.4
3
Technology Hardware & 
Equipment
8.0 14.3 9.1 5.4
4 Leisure Goods 7.3 3.4 5.5 8.6
5 Aerospace & Defence 4.6 5.8 3.2 1.3
6 Automobiles & Parts 4.3 5.4 3.7 4.1
7
Electronic & Electrical 
Equipment
4.3 5.1 3.7 4.6
8
Health Care Equipment & 
Services
4.2 4.4 3.8 7.0
9 Industrial Engineering 2.8 3.7 2.8 1.9
10 Chemicals 2.6 2.1 3.4 3.6
11 General Industrials 2.2 4.5 2.9 1.8
12 Banks 2.0 2.0   
13
Fixed Line 
Telecommunications
1.8 1.8 1.2 2.3
14 Construction & Materials 1.0 0.6 2.5 1.2
15 Oil & Gas Producers 0.3 0.3 0.3 0.2
 Total 40 industries 3.2 2.7 5.0 3.2
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD
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4.4 Growth of net sales and 
profitability by industrial sector
Table 4.3 shows the ranking of the top 15 industrial sectors 
by overall one-year growth of net sales for the companies 
based in the EU, the US and Japan. It also includes the sector 
profitability for these regions.
The following points are observed:
• Worldwide, the Construction & Materials sector shows the 
highest one-year growth rate of net sales (7.9%), followed 
by Automobiles & Parts (7.8%), Software & Computer 
Services (7.2%) and Health Care Equipment & Services 
(7.0%). 
• Among the companies based in the EU, the highest 
growth rates of net sales are in Leisure Goods (6.2%) and 
Software & Computer Services (4.3%). The sector showing 
the lowest one-year sales growth is Fixed Line Telecom 
(-6.6%) followed by Technology Hardware & Equipment 
(-6.2%). Among the largest sectors in the EU, the highest 
profitability is shown in Software & Computer Services 
(17.3%) and Pharmaceuticals & Biotechnology (16.7%). 
The EU companies’ lowest profitability is in the Technology 
Hardware & Equipment sector (4.9%). 
• Among the companies based in the US, the Health Care 
Equipment & Services sector shows the highest one-year 
growth rate for sales (8.7%) followed by Construction 
& Materials (7.2%). Sectors showing the lowest one-
year R&D growth are Oil & Gas Producers (-6.1%) and 
Industrial Engineering (-2.3%). The US-based companies 
have the highest profitability in Software & Computer 
Services (22.0%) and Pharmaceuticals & Biotechnology 
(21.9%). The US companies’ lowest profitability is in the 
Automobiles & Parts sector (4.8%) and    in Health Care 
Equipment & Services (9.4%).  All the other large sectors 
in the US show double-digit profitability.
• For Japanese companies, the highest one-year growth rate 
for sales is shown by Automobiles & Parts (16.1%) and 
Aerospace &Defence (15.3%). The poorest performance is 
shown by the Fixed Line Telecom (2.1%). The profitability 
of companies based in Japan is generally lower than their 
counterparts in the EU and the US, for example 9.9% for 
Pharmaceuticals & Biotechnology, the highest profitability 
sector versus 16.7% and 21.9% for the EU and US 
counterparts. 
• Excluding banks (for which data are only available for EU 
companies), six sectors in the EU show decreases in sales 
compared to two in the US and none in Japan.
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Table 4.3.  Ranking of top 15 industrial sectors by overall one-year sales growth and related data for the EU, 
US and Japanese companies in the 2014 Scoreboard.
Rank
Sector
World-
wide
Sales 
growth 
1y (%)
EU-633 US-804 Japan-387 
Sales 
growth 
1y (%)
Profit.*
Sales 
growth 
1y (%)
Profit.*
Sales 
growth 
1y (%)
Profit.*
1 Construction & Materials 7.9 -0.1 6.6 7.2 10.4 9.3 4.1
2 Automobiles & Parts 7.8 1.8 6.2 4.9 4.8 16.1 7.3
3
Software & Computer 
Services
7.2 4.3 17.3 6.7 22.0 5.0 3.8
4
Health Care Equipment & 
Services
7.0 1.3 14.6 8.7 9.4 9.7 9.8
5
Electronic & Electrical 
Equipment
6.5 1.0 8.5 2.2 11.9 12.1 5.9
6 General Industrials 4.9 1.7 7.1 2.6 12.7 10.5 2.3
7 Aerospace & Defence 4.3 4.3 7.1 3.4 11.0 15.3 6.2
8 Leisure Goods 4.5 6.2 21.5 3.2 12.9 4.5 4.0
9 Chemicals 3.9 -0.7 9.9 3.9 12.8 12.0 5.4
10
Pharmaceuticals & 
Biotechnology
2.8 0.3 16.7 1.6 21.9 8.4 9.9
11
Technology Hardware & 
Equipment
2.2 -6.2 4.9 1.5 16.3 13.7 8.9
12 Industrial Engineering 1.4 -0.5 7.2 -2.3 11.5 12.6 5.8
13 Oil & Gas Producers 0.0 -3.4 7.8 -6.1 11.6 11.9 1.4
14
Fixed Line 
Telecommunications
-2.6 -6.6 13.7 1.1 23.5 2.1 11.1
15 Banks -3.2 -5.7 3.2         
 Total 40 industries 2.8 -2.0 6.9 2.0 13.9 11.5 5.7
* Profitability:  operating profits as percentage of net sales.
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD
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4.5 Changes in indicators by 
region and sector groups
It is interesting to see the distribution of R&D investment 
of the Scoreboard companies across regions and sectors 
using an aggregation of the 40 industrial sectors into four 
groups of high-, medium-high-, medium-low- and low- R&D 
intensity (see Box 1.1 in chapter 1).
The worldwide and domestic distribution of the R&D 
investment by the 2500 Scoreboard companies shows clear 
differences by world region, illustrating respectively the 
weight of the region in the world and its specialisation (See 
Table 4.4): 
• Companies based in the EU specialise in medium-high 
R&D-intensive sectors (45.7% of total R&D of the EU 
companies) and contribute 37.1% of the total world 
R&D of that sector group. Industrial sectors accounting 
for a large share of total world R&D of these sectors 
are Automobiles & Parts (49.6%), Aerospace & Defence 
(51.6%) and Industrial Engineering (40.4%). 
• Those based in the US specialise in high R&D intensive 
sectors (73.8% of total R&D of the US companies) and 
contribute 51.5 % of the world R&D of that sector group. 
Industrial sectors accounting for a large share of total 
world R&D of these sectors are Software & Computer 
Services (75.0%), Technology Hardware & Equipment 
(55.6%) and Pharmaceuticals & Biotechnology (42.8%).
• Japanese companies specialise in medium-high R&D 
intensive sectors (60.0% of total domestic R&D) while 
contributing 25.7% of the world R&D of that sector group. 
The industrial sectors with highest weight in the total 
world R&D are Chemicals (29.5%) and Automobiles & 
Parts (28.2%).  
Table 4.4.  World and domestic R&D distribution of the 2500 Scoreboard companies by sector groups for the 
main regions.
High
Share, %
Medium-high
 Share, %
Medium-low
Share, %
Low
Share, %  Total
world domestic world domestic world domestic world domestic domestic
EU 22.3 38.1 37.1 45.7 38.9 5.9 45.8 10.3 100
US 51.5 73.8 20.2 20.8 31.3 4.0 7.5 1.4 100
Japan 9.8 31.9 25.7 60.0 15.3 4.4 8.7 3.7 100
Other 
countries
16.4 46.9 17.0 35.0 14.5 3.7 38.0 14.4 100
Total world 100 100 100 100  
Note : Sector groups as defined in Box 4.1.
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD
Region
Sector
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4.6 Focus on high R&D-
intensive industries: the EU/US 
R&D gap
This section describes the main characteristics of the 
samples of companies based in the EU and the US for high 
R&D-intensive industries that are important from R&D and 
economic perspectives.  R&D plays an important role for the 
competitiveness of these industries and they have a role as 
enablers for the whole value-chain of key sectors ranging 
from ICT-related industries, transport and health. 
Moreover, EU based companies compared with their main 
counterparts present a weak structural position both in 
terms of number and weight of companies in most of these 
industries. As observed in previous Scoreboard editions, 
the EU gap in these industries is particularly sizeable and 
widening against the US companies. In fact trends observed 
over the past 10 years show a growing dominance of 
US companies in sectors such as Software/Internet and 
Biotechnology where a number of key companies are rapidly 
moving up the R&D rankings (see chapter 2).     
Table 4.5 describes the main characteristics of the companies 
based in the EU and the US in three sub-sectors, namely 
those related with health and ICT.
The salient points from the table are the following:
• In this sample, the Pharmaceuticals sub-sector is the only 
one where the EU and the US have similar number of 
companies, R&D investment and R&D intensity. 
• In the Biotechnology sub-sector, the US dominates the EU 
in number of companies (5 times more numerous), R&D 
investment (10 times larger) and larger average R&D 
intensity per company.
• In the ICT industries the EU/US largest gap is observed 
in number of companies and level of R&D investment, 
especially in Semiconductors and Computer Hardware, but 
also in Software and Internet.
Table 4.5.  Sample of EU and US companies in health and ICT related sectors.
Industry
# companies R&D in 2013 (€m) R&D intensity (%)
EU US EU US EU US
Health  
Pharmaceuticals 47 46 26781.9 29150.0 13.2 14.0
Biotechnology 20 98 1238.4 12287.3 16.0 27.2
Health Care Equip. & 
Services
23 54 2708.2 7483.5 4.4 3.8
IT hardware
Semiconductors 16 77 3895.6 22150.3 17.9 18.5
Computer Hardware 6 27 1081.8 12069.5 8.1 4.1
Telecommunications 
Equipment
12 35 9941.2 13373.8 14.6 14.2
Electronic Office 
Equipment
1 3 57.6 505.3 5.3 2.6
Software & services
Software 33 86 4797.2 22413.9 14.8 15.0
Computer Services 15 46 1311.1 6904.8 5.2 6.9
Internet 2 20 97.6 8811.5 6.3 14.3
Total 175 492 51910.5 135149.8   
Source :  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD
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This chapter discusses the R&D and economic trends of 
companies based in Members States of the EU. This specific 
analysis is based on an extended sample of companies 
representing the top 1000 R&D investors in the EU, i.e. the 
633 EU companies included in the world top 2500 sample 
and 367 additional companies based in the EU.  The main 
questions addressed are firstly about the one-year changes 
in R&D and economic indicators of companies based in the 
top 10 Member States by level of R&D investment. The 
second question regards the long-term trends of company 
results, namely the rate of growth of R&D and net sales and 
profitability for companies based in the top three Member 
States of the EU.
Finally, the performance of EU companies is analysed in 
terms of Value Added (company’s sales less the cost of its 
bought-in goods and services)19, comparing the main ratios 
and efficiency measures of top R&D investing sectors and 
companies.
Key findings
• Companies based in Germany, the top R&D investor, 
continued to increase R&D in 2013, at 5.8%, above the 
world (4.9%) and EU (2.5%) averages. Companies based in 
the UK showed also a significant increase of R&D (4.9%) 
and French companies, on the contrary, reduced R&D 
investment by 3.3%.      
19 Definitions and assumptions taken from the UK 2009 Value Added Scoreboard 
(available on line at http://webarchive.nationalarchives.gov.uk/20100908131539/
http://innovation.gov.uk/value_added/downloads/2009_ValueAdded_Analysis.pdf, last 
access 14/10/2014). To compute the value added we follow the computation formula 
suggested in the data document (available on line at http://webarchive.nationalarchives.
gov.uk/20100908131539/http://innovation.gov.uk/value_added/downloads/2009_
ValueAdded_Data.pdf , last access 14/10/2014), where is reported: “Value Added has 
been calculated as the aggregate of operating profit, employment costs, depreciation, 
amortisation & impairment. It is also equivalent to EBITDA plus employment costs”(pg 
242). We relied on the  “EBITDA plus employment costs” computation formula, using 
data download from the Orbis database. For 2013, it was possible to compute the 
value added for 738 out of the top 1000 R&D investors in the EU.
• Apart from the three top Member States, among the group 
of largest EU countries, those whose companies increased 
R&D above the EU average were Ireland (13.5%), Italy 
(6.4%) and Spain (3.6%). Companies based in three 
countries decreased R&D in 2013: Finland (-10.8%), 
Sweden (-0.5 %) and The Netherlands (-0.1%).  
• The analysis of 10-year trends of R&D and economic 
results for companies based in Germany, the UK and France 
show the effects of the crisis in 2008-2009 and a recovery 
over 2010-2012, especially for the German companies. 
However over the past year the recovery seems stalling 
with companies from the three countries showing a fall 
in net sales. The latter is mostly due to the decrease of 
net sales of large companies in terms of sales but with 
relatively small R&D, e.g. oil companies (Total, Shell, ENI) 
and banks (HSBC).
• The analysis of the performance of EU companies in terms 
of Value Added shows significant differences both between 
and within sectors. The ratio of Value Added to Net Sales 
of the Software & Computer Services sector is more than 
twice that of Automobiles & Parts sector. The largest 
wealth creation efficiency (ratio of value-added to costs of 
employees and depreciation) is found in Pharmaceuticals 
& Biotechnology, three times more ‘efficient’ than the 
Electronic & Electrical Equipment sector. Within each sector 
analysed great differences are observed at company level 
for all value added indicators. For example, among the top 
10 R&D investors in the Chemicals sector, Solvay shows 
the highest ratios of VA to net sales and cost of resources 
(50.0% and 227.5% respectively) whereas Lanxess shows 
the lowest ones (23.6% and 98.8% respectively).  
5 The top 1000 R&D investors in the EU
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5.1 Overview of the EU 1000 
companies  
The composition of the sample of the EU 1000 companies 
across industrial sectors and countries is found in Annex 
3.  This sample, as well as the global 2500, shows a high 
concentration of companies by sector and country. The 6 
largest sectors in terms of R&D account for about 50% of 
the companies. These sectors and the countries accounting 
for at least 15% of the companies each are shown in Table 
5.1:
Table 5.1 Distribution of the EU 1000 companies across main sectors and countries.
Industrial sector* Number of 
companies
Main countries*
Software & Computer Services 110 UK 44;  Germany 20;  France 19
Industrial Engineering 110 Germany 40; UK 14; Sweden 13
Pharmaceuticals & 
Biotechnology
105 UK 30;  France 17; Germany 11
Electronic & Electrical 
Equipment
76 UK 20; Germany 16; FR 10
Technology Hardware & 
Equipment
49 UK 13; Sweden 8; Germany 7
Automobiles & Parts 45 Germany 17; UK 9; France/Italy 6
Total 495  
* Six largest sectors in terms of R&D worldwide and countries whose companies account for more than 15% of the sector within the EU 1000 sample.
Source:   The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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5.2 Trends of companies in the 
top 10 Member States of the 
EU
There are 904 companies based in the top 10 Member 
States accounting for 97.4 % of the total R&D of the 1000 
EU sample (see table 5.2). 
The overall performance of the EU group is largely driven 
by the performance of companies based in Germany, France 
and the UK, accounting for 68.5 % of the total R&D and 68.6 
% of total net sales (see Tables 5.2 and 5.3).  
The 221 German companies in the EU 1000 sample, 
accounting respectively for 36.3% and 26.9% of the total 
R&D and net sales, increased R&D by 5.8% but decreased 
net sales by 1.2%.  These results reflect to a large extent the 
performance of the German companies in the Automobiles 
& Parts sector (+9.7% in R&D and +2.4% in net sales). This 
sector accounts for more than 50% of R&D and 33% of net 
sales of the group of German companies.
The 120 companies based in France, accounting respectively 
for 17.2% and 18.1% of the total R&D and net sales of the 
EU 1000 sample, reduced R&D investment by 3.3% and 
net sales by 3.9%. The largest R&D investing sectors of the 
French sample reduced both R&D and net sales, Automobiles 
& Parts (-8.9% and -2.0%) and Pharmaceuticals & 
Biotechnology (-1.4% and -3.5%).
The 258 companies from the UK, accounting for 14.9% 
and 23.6% of the total R&D and net sales of the EU 1000 
sample, increased R&D investment by 4.9% and reduced net 
sales by 0.4%. The largest R&D investing sectors of the UK 
sample presented contrasting figures, Pharmaceuticals & 
Biotechnology (-0.4% in R&D and -2.0% in net sales) while 
Automobiles & Parts significantly increased both R&D and 
net sales (9.4% and 6.9%). 
Apart from the group of the three top countries, among 
the group of largest EU countries, those whose companies 
increased R&D above the EU average were Ireland (13.5%), 
Italy (6.4%) and Spain (3.6%). Companies based in three 
countries decreased R&D in 2013: Finland (-10.8%), Sweden 
(-0.5 %) and The Netherlands   (-0.1%).  In term of net sales, 
most countries showed negative results, with the exception 
of companies based in Ireland (9.9%) and Denmark (2.0%). 
The poorest figures in net sales were for companies based in 
Italy (-5.2%) and Spain (-4.8%). 
It is important to remember that in many countries, the 
aggregate country indicators depend to a large extent on 
the figures of a very few firms. This is due, either to the 
country’s small number of companies in the Scoreboard or to 
the concentration of R&D in a few large firms. For example:
• The R&D growth of Fiat (2.0%), accounting for about 38 
% of the R&D of companies based in Italy, contributed a 
significant part of the R&D growth of that country.  
• Two companies from the Automobiles & Parts sector, 
accounting for 27.5% of the R&D of companies based in 
Germany, contributed a large part of the that country’s 
R&D growth: Volkswagen (23.4%) and BMW (21.3%). 
 
Table 5.2  R&D trends of companies based in the top 10 EU Member States.
Country No. of companies R&D Share within EU
R&D one year
growth, %
Net sales
One year growth, %
Germany 221 36.3 5.8 -1.2
France 120 17.2 -3.3 -3.9
UK 258 14.9 4.9 -0.4
The Netherlands 49 7.8 -0.1 0.3
Sweden 90 5.8 -0.5 -0.8
Italy 47 5.4 6.4 -5.2
Finland 45 3.0 -10.8 -4.2
Spain 21 2.5 3.6 -4.8
Denmark 32 2.3 2.3 2.0
Ireland 21 2.3 13.5 9.9
Total EU-10 904 97.4 2.5 -1.7
For the sample of 1000 EU companies.
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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Table 5.3.  Ranking of top 15 industrial sectors by one-year R&D growth for the EU 1000 companies and 
related data for German, French and UK companies.
Rank Sector
EU 
1000 
one-
year 
R&D 
growth 
(%)
Germany-221
R&D change (%)    
France-120
R&D change (%) 
UK-258
R&D change (%)
1 year 3 years 1 year 3 years 1 year 3 years
1
Fixed Line 
Telecommunications
8.7 45.2 -7.3 -3.9 -2.6 1.8 -5.7
2
Software & Computer 
Services
7.7 1.5 8.6 11.4 22.5 8.8 9.5
3 Leisure Goods 7.1 15.0 -4.4   15.5 18.9
4 Oil & Gas Producers 6.7   17.9 9.9 3.0 4.9
5 Automobiles & Parts 6.2 9.7 13.6 -8.9 -0.4 9.4 10.3
6
Electronic & Electrical 
Equipment
5.3 1.6 3.5 7.7 5.5 11.6 9.9
7
Health Care Equipment & 
Services
4.9 9.8 11.8 -2.6 3.0 21.5 12.1
8 Banks 4.1 -6.2 17.1 -11.2 13.1 9.2 12.4
9 Aerospace & Defence 3.7 0.7 0.6 13.1 20.9 12.7 4.1
10 Chemicals 3.2 2.2 6.8 -4.0 3.0 6.7 8.4
11 Construction & Materials 2.2 11.2 13.9 -5.3 -0.3 18.4 7.7
12 General Industrials 2.2 4.0 6.3 -2.4 16.2 3.7 1.3
13 Industrial Engineering 1.1 5.1 8.3 4.2 2.0 16.3 14.2
14
Pharmaceuticals & 
Biotechnology
0.8 0.6 2.3 -1.4 3.9 -0.4 0.4
15
Technology Hardware & 
Equipment
-5.4 3.1 5.0 -3.0 -3.0 7.8 18.3
Total 2.5 5.8 9.1 -3.3 3.0 4.9 5.0
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD
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5.3  Long-term performance of 
companies based in the 3 top 
EU Member States
The annual growth rates of R&D investment and net sales 
and profitability of companies based in Germany, France and 
the UK is provided respectively in figures 5.1, 5.2 and 5.3 
for the period 2005-2013. These figures are based on our 
history database comprising R&D and economic indicators 
over the whole 2005-2013 period from the EU 1000 dataset, 
including 151 from Germany, 87 from France and 157 from 
the UK. 
The trends observed in these figures show the behaviour 
of these companies including the effects of the crisis that 
began in 2008. The following points are observed:   
• Companies based in Germany showed a good performance 
over the period 2010-2012, recovering the levels of 
growth prior to the crisis, especially in terms of R&D. In 
the last period, they continued to increase R&D at slower 
pace while maintaining a stable level of profitability but 
showing a decline in net sales.      
• Companies based in France showed a recovery in R&D and 
net sales in 2010-2011, however, over the last period they 
presented an important decline in both net sales and R&D 
growth. The average profitability of the French companies 
shows a decreasing trend since 2011. 
• Companies based in the UK showed a strong recovery of 
R&D and net sales in 2010-2011 that was broken up in 
2012. Over the last period their R&D investment resumed 
to grow at significant pace but with a level of net sales 
practically unchanged. The average profitability of the 
UK companies, like their French counterparts, shows a 
decreasing trend since 2011.
Figure 5.1. One-year R&D investment and net sales growth and profitability by the German companies.
Note: For 151 out of the 221 German companies in the EU1000 with data for the whole period. Profitability is the ratio of operating profit to net sales. 
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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Figure 5.2. One-year R&D investment and net sales growth and profitability by the French companies.
Note: For 87 out of the 120 French companies in the EU1000 with data for the whole period. Profitability is the ratio of operating profit to net sales 
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
Figure 5.3. One-year R&D investment and net sales growth and profitability by the UK companies.
Note: For 157 out of the 258 UK companies in the EU1000 with data for the whole period. Profitability is the ratio of operating profit to net sales.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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5.4 R&D intensity trends by 
companies based in selected 
Member States
 
In 2013, for the third consecutive year, the average R&D 
intensity of the EU-1000 companies increased because of 
the higher increase of R&D investments compared to that of 
net sales, 2.5% vs. -1.8% (see Figure 5.4). 
It is important to remember that a few large but low R&D 
intensity companies have a big effect on some country 
average R&D intensities. One example is Shell and BP for 
the UK. In The 2014, these companies contributed 40.4% 
of the UK’s Scoreboard company sales, so if these two 
companies had been left out, the average R&D intensity of 
UK companies would had increased by 55% (from 1.66% to 
2.58%). Large banks such as HSBC and mining companies 
have a similar but smaller effect in the UK.
Figure 5.4. Trends in R&D intensities for EU Scoreboard companies in selected Member States.
For the EU1000 companies in each of the eleven Scoreboards 2004-2014
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
T h e  2 0 1 4  E U  I n d u s t r i a l  R & D  I n v e s t m e n t  S c o r e b o a r d
64
5.5 Performance of companies 
in terms of Value Added
In this section, the performance of the top 1000 R&D 
investors in the EU is analysed in terms of their 2013 Value 
Added for the largest R&D investors and sectors.
The R&D intensities, expressed as a percentage of Value 
Added and net sales are reported for eight selected sectors in 
Figure 5.5. This figure shows that the differences between the 
two R&D intensities vary significantly from the Automobiles 
& Parts sector, showing the largest difference, to the Software 
& Computer Services sector showing the lowest. This reflects 
sector-specific differences of the ratio Value Added to net 
sales discussed in the following paragraphs. 
Figure 5.5 R&D intensities in terms of Value Added and Net Sales by sector.
Note: Only the top 8 sectors in terms of R&D investment are included. Between brackets the number of companies per sector for which it was possible 
to compute the ratio. Overall 442 companies out of 564.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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Value Added expressed as a percentage of net sales is 
reported for the eight selected sectors in Figure 5.6. This 
gives a first idea of the differences among sectors in terms 
of Value Added. The sector “Software & Computer Services” is 
the one with the highest value (63.5 %), while “Automobiles 
& Parts” is the one with the lowest (29.3%).
Value Added can be used to compute two interesting 
measures of performance. The first one is the Value Added 
per employee, which is a measure of labour productivity 
(reported in Figure 5.7). In this case the sector showing the 
highest value is Pharmaceuticals & Biotechnology (€158.7k 
per employee), while Industrial Engineering and Electronic & 
Electrical Equipment show the lowest (€80k per employee). 
Differences among sectors can be inflated in cases where 
one or more companies in a sector have a high number of 
part time and/or low paid employees. 
Figure 5.6. Value Added as percentage of Net Sales by sector.
Note: Only the top 8 sectors in terms of R&D investment are included. Between brackets the number of companies per sector for which it was possible 
to compute the ratio. Overall 442 companies out of 564.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
Figure 5.7. Value Added per employee (in € per person employed) by sector.
Note: Only the top 8 sectors in terms of R&D investment are included. Between brackets the number of companies per sector for which it was possible 
to compute the ratio. Overall 434 companies out of 564.
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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The second one is the Value Added as a percentage of 
employee costs plus capital depreciation, which is a measure 
of wealth creation efficiency (reported in Figure 5.8). As 
for labour productivity, Pharmaceuticals & Biotechnology 
(188%) and Chemicals (158%) are the sectors with the 
highest values, while in this case the lowest values are 
shown by Electronic & Electrical Equipment (128%) followed 
by Aerospace & Defence (134%). Unlike Value Added per 
employee, the measure of Value Added as a percentage of 
employee costs plus capital depreciation is not affected by 
the problem of exaggerated sectorial differences due to the 
presence of part time or low paid workers, given it’s based on 
total costs and not on headcount. If for a sector or a company 
the Value Added as a percentage of employee costs plus 
capital depreciation is 100%, then the sector or the company 
is creating as much Value Added as the resources used to 
produce it. So to be sustainable in the long run, a sector or 
a company needs a value significantly over 100% (let’s say 
120% or more). This is because need to build up reserves to 
survive temporary dips in sales and profits due to recessions 
or business/product cycles.
Figure 5.8. Value Added as percentage of employee costs and capital depreciation by sector.
Note: Only the top 8 sectors in terms of R&D investment are included. Between brackets the number of companies per sector for which it was possible 
to compute the ratio. Overall 391 companies out of 564.
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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The figures briefly discussed at sector level actually hide a 
great variation within each sector at company level. Table 
5.4 reports the values of the three ratios computed for the 
top 10 R&D investing companies in each of the top eight 
sectors as  well as the R&D intensities calculated in terms of 
Value Added and net sales.
A great variation can be observed in each of them for all the 
three indicators.
For example, looking at the three top sectors of Figure 
5.8 (“Pharmaceuticals & Biotechnology”, “Chemicals” 
and “Software & Computer Services”) and comparing the 
companies within each sector according to their efficiency 
(measured as Value Added as a percentage of employee 
costs plus capital depreciation), gives an idea of how big 
these differences are.
The rank of the 10 companies in the table according to their 
efficiency, in the “Pharmaceuticals & Biotechnology” sector, 
shows that the first one (Shire), is 6.5 times more efficient 
than the last one (Boehringer Ingelheim). Excluding the first 
and the last, the difference between the second (Actavis) and 
the ninth (Bayer) in terms of efficiency is still significant (3.1 
times).
Replicating the same example for the “Software & Computer 
Services” sector provides a similar picture. The difference in 
efficiency between the first (AVG technologies) and the tenth 
(Sopra) of the rank is 7.5 times, while the difference between 
the second (Amdocs) and the ninth (Indra Sistemas) is 4.0 
times.
In the “Chemicals” sector, the differences are less extreme, 
but they are still significant. There is a 2.3 times efficiency 
difference between the first (Solvay) and the tenth (Laxness) 
company of the rank and a 1.6 times difference between the 
second (Johnson Matthey) and the ninth (Wacker Chemie).
Company Country R&D/Net Sales (%)
R&D/VA 
(%)
VA/Net 
Sales (%)
VA/EMP (€ 
per person 
employed)
VA/(Employee 
Costs + 
Depreciation) (%)
Aerospace & Defence
AIRBUS Netherlands 6.0 20.2 29.9 122.9 120.3
FINMECCANICA Italy 10.9 30.8 35.4 88.8 115.8
SAFRAN France 8.0 16.8 47.5 103.9 143.9
ROLLS-ROYCE UK 4.3 11.0 38.7 130.0 148.5
DASSAULT AVIATION France 10.2 17.2 59.6 236.2 267.1
ZODIAC AEROSPACE France 6.7 14.4 46.6 72.0 150.9
BAE SYSTEMS UK 1.1 2.5 43.1 111.3 135.3
SAAB Sweden 5.6 10.8 51.9 98.4 117.6
MTU AERO ENGINES Germany 3.7 12.8 28.7 123.3 156.1
MEGGITT UK 6.7 10.8 62.7 111.0 171.5
Automobiles & Parts 
VOLKSWAGEN Germany 6.0 20.3 29.4 101.2 135.5
DAIMLER Germany 4.6 15.7 29.1 125.0 157.9
BMW Germany 6.3 22.9 27.5 189.6 182.3
CONTINENTAL Germany 5.8 15.7 36.7 68.8 145.4
RENAULT France 4.4 20.0 22.0 73.8 117.2
VALEO France 6.4 20.0 32.1 52.0 130.7
MICHELIN France 3.2 7.7 41.1 74.8 132.9
GKN UK 2.7 7.4 37.3 74.0 127.8
RHEINMETALL Germany 4.9 13.8 35.6 77.9 112.2
PIRELLI Italy 3.2 8.7 37.3 60.4 154.0
Table 5.4  R&D intensities in terms of Value Added and Net Sales and ratios of Value Added to Net Sales, 
employees and costs of resources.
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Company Country R&D/Net Sales (%)
R&D/VA 
(%)
VA/Net 
Sales (%)
VA/EMP (€ 
per person 
employed)
VA/(Employee 
Costs + 
Depreciation) (%)
Chemicals
BASF Germany 2.5 9.6 26.0 171.3 162.9
DSM Netherlands 5.5 18.4 30.0 118.4 140.0
EVONIK INDUSTRIES Germany 3.0 8.1 37.1 141.8 132.7
AKZO NOBEL Netherlands 2.2 6.9 31.3 93.8 135.9
SOLVAY Belgium 2.2 4.3 50.0 218.8 227.5
L’AIR LIQUIDE France 1.3 3.0 42.3 128.2 165.4
LANXESS Germany 2.2 9.5 23.6 112.8 98.8
WACKER CHEMIE Germany 3.9 9.7 40.2 112.4 106.6
JOHNSON MATTHEY UK 1.3 12.0 10.4 120.4 171.9
ARKEMA France 2.4 8.1 29.3 132.3 147.3
Electronic & Electrical Equipment
SIEMENS Germany 6.0 13.2 45.6 94.4 122.4
SCHNEIDER France 3.5 8.1 42.6 61.5 153.8
TOMTOM Netherlands 19.2 40.1 47.9 125.6 178.3
AGFA-GEVAERT Belgium 5.1 12.2 41.6 108.0 120.6
SMITHS UK 3.6 7.7 47.2 75.3 160.7
INGENICO France 8.1 18.9 43.0 126.3 171.2
BARCO Belgium 9.3 27.0 34.4 100.2 130.0
SPECTRIS UK 7.4 13.6 54.2 106.0 150.9
LEONI Germany 2.7 10.0 26.8 17.1 121.2
NEXANS France 0.0 0.1 18.5 48.0 91.3
Industrial Engineering
VOLVO Sweden 6.9 26.3 26.3 85.4 117.7
ALSTOM France 5.0 13.5 36.9 86.8 121.0
SANDVIK Sweden 3.8 8.6 44.1 90.5 131.6
HEXAGON Sweden 11.3 18.3 61.6 107.5 166.2
ATLAS COPCO Sweden 2.9 6.3 45.6 107.6 189.7
WARTSILA Finland 4.7 12.6 37.0 92.4 147.5
SKF Sweden 2.9 29.4 9.9 14.7 270.5
CLAAS Germany 5.2 19.7 26.2 103.5 154.1
DANFOSS Denmark 4.1 9.5 43.2 86.5 139.3
KRONES Germany 5.8 15.3 37.9 87.0 123.9
Pharmaceuticals & Biotechnology
SANOFI-AVENTIS France 14.4 25.2 57.3 168.3 193.0
GLAXOSMITHKLINE UK 13.1 20.6 63.8 202.4 200.9
BAYER Germany 8.1 19.0 42.7 151.7 159.4
ASTRAZENECA UK 17.2 32.6 52.7 190.6 215.5
BOEHRINGER INGELHEIM Germany 19.5 39.9 48.8 144.7 145.8
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Company Country R&D/Net Sales (%)
R&D/VA 
(%)
VA/Net 
Sales (%)
VA/EMP (€ 
per person 
employed)
VA/(Employee 
Costs + 
Depreciation) (%)
NOVO NORDISK Denmark 14.0 19.9 70.2 207.1 218.0
MERCK DE Germany 13.6 22.3 60.8 176.8 190.0
UCB Belgium 25.6 47.8 53.6 187.2 160.5
SHIRE UK 18.0 45.2 39.9 285.3 959.8
ACTAVIS Ireland 7.1 37.2 19.1 62.6 494.0
Software & Computer Services
SAP Germany 13.6 17.7 76.8 194.1 164.8
AMADEUS Spain 16.3 24.8 65.7 194.2 177.0
DASSAULT SYSTEMES France 18.2 41.5 43.8 84.9 301.2
INDRA SISTEMAS Spain 6.7 11.2 60.0 45.3 115.7
AMDOCS UK 7.2 35.4 20.3 23.7 458.7
SAGE UK 10.5 13.9 75.5 93.7 161.6
SOFTWARE AG Germany 11.1 13.7 81.0 150.4 145.6
WINCOR NIXDORF Germany 4.0 12.0 33.5 93.5 120.1
SOPRA France 5.7 7.4 77.2 64.0 113.6
AVG TECHNOLOGIES Netherlands 15.0 42.2 35.5 142.6 849.0
Technology Hardware & Equipment
NOKIA Finland 14.7 70.6 20.9 88.7 108.5
ALCATEL-LUCENT France 16.4 44.9 36.6 84.9 103.7
STMICROELECTRONICS Netherlands 23.2 49.7 46.8 60.4 92.2
SEAGATE TECHNOLOGY Ireland 8.4 28.2 29.9 57.4 480.4
ASML HOLDING Netherlands 16.0 32.1 49.9 252.7 214.0
INFINEON TECHNOLOGIES Germany 15.0 26.5 56.5 81.3 120.1
NXP SEMICONDUCTORS Netherlands 13.3 22.5 58.9 80.0 159.3
CSR UK UK 28.2 73.0 38.7 127.2 118.3
DIALOG SEMICONDUCTOR UK 17.4 53.2 32.6 194.2 180.4
PACE PLC UK 5.7 39.7 14.3 142.8 210.8
Note: Only 10 companies for each of the top 8 sectors in terms of R&D investment are included. Companies selected according to their position in the 
R&D investment ranking within each sector. Only companies for which was possible to compute the three indicators were included
Source: The 2014 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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This chapter presents an analysis of the R&D and economic 
performance of the EU companies at the lower reaches 
of the R&D ranking. The objective is to identify potential 
leading innovators and to understand the factors underlying 
successful trajectories. 
The analysis is based on a sample of 500 companies from 
the lower part of the 1000 EU R&D company ranking in 
the 2014 Scoreboard. This sample consists of middle-size 
companies that invested in R&D between 5 and 50 million 
Euros in 2013. 
The first section characterises a filtered sample of companies 
relying on a set of corporate R&D performances between 
2005 and 2013. The investigation goes further to identify top 
companies with the best R&D and economic performance. 
The last section analyses the evolution of companies in 
the EU R&D ranking over the period 2006-2013. It focuses 
on the mergers and acquisitions (M&As) and foreign 
direct investments (FDIs) in the dynamics of the selected 
companies.
Key findings
• About a half of the examined sample of companies (248 
high and medium-high technology companies out of the 
500 at the bottom of the R&D ranking) showed R&D 
intensity higher than 1% and a significant R&D growth 
over 2005-2013. Two- thirds of these companies operate 
in ICT- and health-related sectors and concentrate in a few 
Member States, namely the United Kingdom, Germany, 
Sweden and France. 
• The top 37 companies showing the best R&D and 
economic performance operate mainly in Software & 
Computer Services (8), Electronic & Electric Equipment 
(6) and Industrial Engineering (6). The top countries are 
similar to that of the first selected sample, but Sweden 
now comes second among the highest performers. Within 
the top companies, 18 were found to have engaged in FDIs 
projects, mainly in China, the US, Romania and Thailand.
• Out of the 482 companies at the bottom of the 2007 R&D 
Scoreboard (2006 data), 181 companies survived and 
continue to be in the 2014 Scoreboard. Of the remaining 
companies, 127 have been acquired or merged.   
Overview of the EU 500 lower 
reaches
The distribution of the lower reaches of the Scoreboard shows 
a high concentration at the country and sector levels (see 
Figure 6.1). Five countries, Germany, the United Kingdom, 
France, Sweden and Finland account for about 80% of the 
total number of companies in the selected six sectors (about 
70% of the upper reaches of the EU 1000). The United 
Kingdom, Germany, France and Sweden account respectively 
for about 30%, 20%, 14% and 10% of the companies.
y distribution of the EU 1000 in 6 top sectors
6 Potential leading innovators in the EU
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This group of EU companies, as well as the global 2500, 
shows a high concentration of companies by sector and 
country. The 9 largest sectors account for about two-thirds 
of the 500 companies. These sectors and the associated 
most representative countries are presented below:
Figure 6.1 Distribution of the upper and lower reaches of EU 1000 in top countries (selected sectors).
Note: 374 companies – Industrial classification: ICB 3 digit
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD
Selected sectors Total companies
Top countries (# companies) and sector 
concentration (1)
Software & Computer Services 72 UK 30, Germany 15, France 10 76%
Industrial Engineering 54 UK 9, Germany 17 48%
Pharmaceuticals & Biotechnology 50 UK 19, Germany 17 72%
Electronic & Electrical Equipment 39 UK 12, Germany 8 51%
Support Services 27 UK 15, Germany 9 89%
Construction & Materials 24 Germany 5, Belgium 4 38%
General Industrials 22 UK 6, Sweden 6, Germany 5 77%
Technology Hardware & Equipment 22 UK 7, Sweden 6 59%
Chemicals 21 UK 7, Sweden 4, Germany 4 71%
Total 331 215 65%
(1) Sector shares of the top countries (number of companies)
Source:  The 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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6.1 High-performance R&D 
investors in the EU 500 lower 
reaches
This section introduces a first distinction of companies 
on the basis of several criteria detailed in the Box 6.1. An 
initial criterion, the R&D intensity, separates the companies 
according to the relative level of resources devoted to R&D. 
A second classification considers the growth patterns of 
corporate R&D investments. Here the analysis accounts for 
both the short and longer term changes in R&D investments. 
A third focus is made on companies that operate in high and 
medium-high technology companies. The application of such 
criterion intends to address the relative shortfall of EU R&D 
spending, particularly in high and medium-high technology 
industries.
Box 6.1. Selection of high-performance EU companies.
The following criteria are considered :
(1) The R&D intensity:  an initial distinction is made at a 1% threshold of corporate R&D intensity in 2013. 
Among the EU 500 lower reaches companies, 381 companies have a value of R&D intensity superior to 
1%. 
(2) The growth pattern of R&D investment: companies are further excluded on the basis of their pattern 
of R&D growth over and across periods. The average of the annual growth rates (AAGr) and the 
compound annual growth rate (CAGr) of R&D investments are computed for the period 2005-2013 
for the first restricted sample. The following table presents the distribution of negative and positive corporate 
growth rates according to the computational method considered.
(1) Total : 378 companies - three firms in the 381-companies sample enter in 2013 in the ranking
In order to consider the performances of companies on the short and longer term, only companies with 
a positive average of the annual growth rates and a positive compound annual growth rate of R&D 
expenditures are maintained in the sample. The combination of these two indicators allows attenuating the 
potential impact of the high annual fluctuations observed. On the same basis, companies that enter in the 
ranking in the last year are not included, as well as companies with few available evidence with respect to 
the R&D and Net sales growth.
(3) High and medium-high technology sectors: only the companies that operate in high and medium-high 
technology industries are maintained in the sample. 
(1)
Number of 
positive corporate 
rates
Number of 
negative 
corporate rates
Number of overlapping 
positive and negative 
corporate rates
Average of Annual Growth 
rates (AAGr) 343 35 # Positive rates: 318
# Negative rates : 34Compound Annual Growth 
rate (CAGr) 319 59
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The application of the above-mentioned filters leads to a 
sample of 248 high-performances EU companies, out of 
the 500 originally considered. This sub-group includes 119 
companies that operate in high-technology sectors and 
129 in the medium-high technology sectors. The Figure 6.2 
shows the distribution of the companies by industrial sector.
Figure 6.2 Sector distribution of high R&D performers.
Note: 248 companies – Industrial classification: ICB 3 digit
‘Other’ include two companies in each of the sectors of Leisure goods, Personal goods and Travel and leisure  
Source:  The 2014 EU Industrial R&D Investment Scoreboard 
European Commission, JRC/DG RTD.
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The sector distribution reveals that: 
• As with the initial sample of companies, this sub-group 
shows a high concentration pattern. Indeed the top four 
sectors are identical for the two samples.
• About half of these companies operate in three sectors 
(48.4%) including Software and computer services, 
Industrial engineering and Pharmaceuticals and 
biotechnology, respectively. This proportion rises to two-
thirds of the filtered sample when the Electronic and 
electrical equipment and Technology hardware and 
equipment sectors are additionally taken into account.
• Relatively less representative industries, for which the 
total number of companies is below 10, include notably 
the sectors of General Industrials, Aerospace & Defence, 
Household Goods and Home Construction and Financial 
Services.
The Figure 6.3 compares the sector distribution of companies 
by country of origin. The following points can be observed:
• The country distribution shows a very high concentration 
in two countries, namely the United Kingdom (29.8% of 
the 248 companies) and Germany (22.6%), which together 
account for more than half of the EU R&D investors 
selected.  Besides these two, one fourth of these companies 
come from Sweden (12.5%) and France (11.5%).
• The countries exhibit different sector distributions of 
companies with a prevalence of two to four sectors, 
revealing an important concentration at the individual 
country level.
• In general countries with a high number of companies 
are also those which display the broadest coverage with 
respect to sector origin. Indeed the UK, German and 
Sweden groups of companies are present respectively in 
15, 13 and 12 sectors out of the 16 considered here.
Figure 6.3. Distribution of  the EU High-performance R&D investors by country and sector.
Note: 248 companies – Industrial classification: ICB 3 digit
Source:  The 2014 EU Industrial R&D Investment Scoreboard  
European Commission, JRC/DG RTD.
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6.2 The top EU potential leading 
innovators 
This second section presents the finest sample which includes 
37 EU R&D investors from the lower reach with the most 
outstanding performances in terms of R&D and economic 
indicators. The selection of the top companies is made on 
the basis of the following criteria:
• 100 out of 248 companies have a compound annual 
growth rate of R&D superior to 15%.  
• Among these R&D investors, only the companies with 
relatively higher performances with respect to their net 
sales and operating profits are further maintained in the 
sample. In other words the focus is made on companies 
with a compound annual growth rate of net sales above 
10% (2010-2013) and positive operating profits in the last 
year. 
The Table 6.1 gives more details on the sector of origin, the 
R&D and economic performances (net sales, employment 
and operating profits) of the top 37 EU potential leading 
innovators meeting these conditions and having an R&D 
intensity superior to 2%. The top companies identified are 
ranked according to their level of R&D investments (or 
equivalent rank in the top 1000 EU companies). The following 
points can be observed:
• Companies are equally distributed across medium-high 
and high technology sectors (resp. 19 and 18 companies). 
• The group of top companies shows the same country 
distribution as the 248-companies sample, with UK, 
Sweden and Germany accounting for more than two thirds 
(27 companies). Note however that Sweden accounts 
for 8 companies from 7 different sectors and Germany 
represents 7 of the top lower reaches companies from 
6 different sectors. The companies based in the UK 
are present in 5 sectors; this indicates a higher sector 
concentration as compared to the first restricted sample 
of 248 companies. 
• With respect to the sector distribution, the Software & 
Computer Services sector is still leading the sector picture, 
while companies from the group of Electronic & Electrical 
Equipment companies (6) come second as for the group of 
Industrial Engineering companies (6).  
• Looking at the other indicators, the table also shows that the 
Swedish company, Systemair from Industrial Engineering 
sector records the highest number of employees of the 
sample (4250 employees). In terms of operating profits 
in 2013 (but not in profitability) the Belgian firm Picanol 
performs better than the other companies in the 37 
selected. 
• In terms of R&D intensity, 5 companies have a value above 
20%, including two companies from the UK. The majority 
of companies have an intensity ranging between 3% 
and 20% (26 companies including 14 between 10% and 
20%), and there are 8 companies from the Software and 
computer services sector with intensity between 7.5% and 
23.8%.
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6.3 The dynamics of the lower 
reaches of the EU ranking: a 
look at M&As and FDIs 
This last section examines the trajectory of the lower 
reaches. It presents their dynamics in terms of M&As and 
FDIs in the last decade.
The first sub-section provides some stylized facts on the 
R&D investors that are still in the EU Scoreboard 2014, have 
merged or been acquired on the period 2007-2013. In this 
respect, the initial sample includes 181 companies, out of 
the 482 lower reaches (see the 2007 Scoreboard), and 127 
companies that have been either acquired or merged.
The surviving R&D investors between 2006 and 2013
Among the year 2006, companies that are still recorded in 
the latest Scoreboard, only one fifth were able to position 
themselves among the EU top 500 (35 companies), including 
two now in the world top 500. Indeed a closer examination of 
the net sales growth rate reveals that these 35 R&D investors 
have recorded a higher average growth as compared to the 
greatest part of the 181 companies (respectively 43% and 
30%). 
Figure 6.4 provides the sector distribution of the companies 
that belong to both the 2007 and 2014 EU Scoreboards. It 
distinguishes in the right quadrant those R&D investors that 
have climbed up to the EU top 500. It mainly shows that 
Software and Industrial machinery are the main sectors of 
activities for the initial sample of companies while the 35 
R&D investors, which are now part of the EU top 500, mainly 
come from the sectors of Pharmaceutical, Biotechnology 
and Construction and materials.
Figure 6.4 The sector distribution of surviving EU companies.
Notes: 181 companies ranked in the EU top 1000 in 2007 and 2014 Notes: 35 companies that climbed up to the EU top 500
Source:  The 2007 and 2014 EU Industrial R&D Investment Scoreboard. 
European Commission, JRC/DG RTD.
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The M&As and FDIs in the EU lower reaches 
During the period 2007-2013, 127 companies out of the 
482 lower reaches have gone through M&As. 
Figure 6.5 reports the distribution of this group by acquiror 
and target country. Companies located in the United Kingdom, 
Germany, the US and the Netherlands are responsible for 
about 48% of the acquisitions, while about half of the 
mergers and acquisition deals are achieved in the United 
Kingdom and Germany. 
Figure 6.6 displays the distribution of the acquired companies 
by country and R&D intensity category. A total of 49 UK 
companies were acquired, especially in the high-tech sectors 
(29 out of the 49 acquired companies). France, Belgium and 
Denmark also present a quite high proportion of acquired 
companies from the high-technology sectors, whereas most 
companies acquired in Germany, Finland, Italy, Sweden, 
Austria, and the Netherlands, were operating in the medium-
technology sectors.
Figure 6.5 Distribution of 127 lower reach companies by acquirer and target country.
Notes: 127 companies
Source: The 2007 and 2014 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD 
and Zephir database by Bureau van Dijk.
Figure 6.6 Distribution of the acquired companies by country and R&D intensity group.
Notes: 127 companies
Source: The 2007 and 2014 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD 
and Zephir database by Bureau van Dijk.
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The international activities of the top 37 EU potential 
leading companies
Among the top 37 EU potential leading companies, 18 were 
found to have engaged in foreign investments. In particular, 
Table 6.2 reports the millions of Euro spent in the top 10 
destination countries (representing 80% of total capital) by 
main business activity. It mainly reveals that:
• US, Thailand, China and Romania are together the recipient 
countries of almost 50% of capital expenditures with the 
US having 22.5%. 
• The top 37 most promising companies did not record FDI 
investments in research.
• The 37 EU most promising companies had invested in the 
US, especially in development (design, development & 
testing) which is their fifth (out of eight) most important 
business activity.
• Investments in manufacturing and business services 
constitute more than 80% of the capital expenditure in 
the top 10 destination countries.
Table 6.3 lists the 18 companies by capital expenditures 
dedicated to the setting up of new facilities abroad 
(greenfield FDIs).
Table 6.2 FDI by destination country and business activity (millions of euro).
Top 10 
Destination
Countries
Manufacturing Business Services
Maintenance 
& Servicing
Sales, 
Marketing 
& Support
Design, 
Development 
& Testing
Other business 
activities Total
Thailand 83.8 83.8
United 
States
80.5 8.2 15.6 12.7 117.0
Brazil 34.5 1.8 36.3
Russia 28.2 9.9 38.1
China 26.8 19.6 8.3 54.6
Romania 17.2 32.0 49.3
Slovakia 4.7 32.0 3.9 40.6
Lithuania 4.3 32.0 36.4
Estonia 32.0 32.0
Slovenia 32.0 32.0
Total 280.0 170.0 19.6 18.3 15.6 16.6 520.0
Notes: 18 parent companies. Capex figures shown in the table are in EUR - Euro millions. Capex data includes estimated values from the Financial 
Times Ltd.
Source: The 2014 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD and © fDi Intelligence, from the Financial Times Ltd  
2014.
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Table 6.3 Greenfield FDI projects by the top 50 EU potentially leading companies.
Parent company Projects Capex Jobs Created Companies
S&T 8 178.2 646 3
SMARTRAC 5 113.5 2000 1
SAF-HOLLAND 10 60.0 429 1
MANITOU BF 2 58.1 458 1
SYSTEMAIR 6 35.6 450 2
GOOCH & HOUSEGO 2 33.8 118 1
LPKF LASER & 
ELECTRONICS
6 26.7 245 2
MANZ AUTOMATION 2 25.2 307 1
TRANSMODE 4 18.6 136 1
PICANOL 2 17.2 372 2
MUNTERS 2 16.6 125 1
CRANEWARE 3 15.9 248 1
KENDRION 3 12.6 227 3
MEGGER 3 12.0 83 1
HMS NETWORKS 3 11.2 106 1
VITROLIFE 2 9.4 27 1
THROMBOGENICS 1 8.4 40 1
ABCAM 3 7.0 57 1
Total 67 660.0 6074 25
Notes: 18 parent companies. Capex figures shown in the table are in EUR - Euro millions. Capex and Jobs data includes estimated values from the   
Financial Times Ltd.
Source: The 2014 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD and © fDi Intelligence, from the Financial Times Ltd  
2014.
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The Scoreboard is part of the European Commission’s 
monitoring activities to improve the understanding of trends 
in R&D investment by the private sector and the factors 
affecting it. It was created in response to the Commission’s 
Research Investment Action Plan20, which aims to help close 
the gap between the EU’s R&D investment and that of other 
developed economies.
The annual publication of the Scoreboard is intended to raise 
awareness of the importance of R&D for businesses and to 
encourage firms to disclose information about their R&D 
investments and other intangible assets.
The data for the Scoreboard are taken from companies’ 
publicly available audited accounts. As in more than 99% 
of cases these accounts do not include information on the 
place where R&D is actually performed, the company’s 
whole R&D investment in the Scoreboard is attributed to the 
country in which it has its registered office21. This should be 
borne in mind when interpreting the Scoreboard’s country 
classifications and analyses. 
The Scoreboard’s approach is, therefore, fundamentally 
different22 from that of statistical offices or the OECD when 
preparing Business Enterprise Expenditure on R&D (BERD) 
data, which are specific to a given territory. The Scoreboard 
data are primarily of interest to those concerned with 
benchmarking company commitments and performance (e.g. 
companies, investors and policymakers), while BERD data are 
primarily used by economists, governments and international 
organisations interested in the R&D performance of territorial 
units defined by political boundaries. The two approaches are 
therefore complementary. The methodological approach of 
20 “Investing in research: an action plan for Europe”, COM(2003)266, http://europa.
eu.int/eur-lex/en/com/cnc/2003/com2003_0226en02.pdf. 
21 The registered office is the company address notified to the official company 
registry. It is normally the place where a company’s books are kept.
22 The Scoreboard refers to all R&D financed by a company from its own funds, 
regardless of where the R&D is performed. BERD refers to all R&D activities performed 
by businesses within a particular sector and territory, regardless of the location of 
the business’s headquarters, and regardless of the sources of finance. The sources 
of data also differ: the Scoreboard collects data from audited financial accounts and 
reports whereas BERD typically takes a stratified sample, covering all large companies 
and a representative sample of smaller companies. Additional differences concern the 
definition of R&D intensity (BERD uses the percentage of R&D in value added, while 
the Scoreboard considers the R&D/Sales ratio) and the sectoral classification (BERD 
uses NACE (the European statistical classification of economic sectors), while the 
Scoreboard uses the ICB (the International Classification Benchmark).
the Scoreboard, its scope and limitations are further detailed 
in Annex 2 below.  
Scope and target audience
The Scoreboard is a benchmarking tool which provides 
reliable up-to-date information on R&D investment and 
other economic and financial data, with a unique EU-focus. 
The 2500 companies listed in this year’s Scoreboard account 
for more than 90%23 of worldwide business enterprise 
expenditure on R&D (BERD). The data in the Scoreboard are 
published as a four-year time-series to allow further trend 
analyses to be carried out, for instance, to examine links 
between R&D and business performance.
The Scoreboard is aimed at three main audiences. 
Companies can use the Scoreboard to benchmark their R&D 
investments and so find where they and their competitors 
stand in the EU and in the global industrial R&D landscape. 
This information could be of value in shaping business or 
R&D strategy. 
Investors and financial analysts can use the Scoreboard 
to assess investment opportunities and risks.
Policy-makers, government and business organisations 
can use R&D investment information as an input to policy 
formulation or other R&D-related actions and to assess the 
need for changes to the business environment to encourage 
the formation and growth of profitable R&D companies in 
sectors appropriate for specific countries.
Furthermore, the Scoreboard dataset has been made freely 
accessible so as to encourage further economic and financial 
analyses and research by any interested parties.
23 According to latest Eurostat statistics. However BERD and Scoreboard figures are 
not directly comparable.
Annex 1 - Background information
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The data for the 2014 EU Industrial R&D Scoreboard 
(the Scoreboard) have been collected from companies’ 
annual reports and accounts by Bureau van Dijk Electronic 
Publishing GmbH (BvD). The source documents, annual 
reports & accounts, are public domain documents and so the 
Scoreboard is capable of independent replication. 
Main characteristics of the data
The data correspond to companies’ latest published accounts, 
intended to be their 2013 fiscal year accounts, although due 
to different accounting practices throughout the world, they 
also include accounts ending on a range of dates between 
late 2012 and early 2014.  Furthermore, the accounts of 
some companies are publicly available more promptly than 
others. Therefore, the current set represents a heterogeneous 
set of timed data.
In order to maximise completeness and avoid double 
counting, the consolidated group accounts of the ultimate 
parent company are used. Companies which are subsidiaries 
of any other company are not listed separately. Where 
consolidated group accounts of the ultimate parent company 
are not available, subsidiaries are included.
In case of a demerger, the full history of the continuing entity 
is included. The history of the demerged company can only 
go back as far as the date of the demerger to avoid double 
counting of figures.
In case of an acquisition or merger, pro forma figures for 
the year of acquisition are used along with pro-forma 
comparative figures if available. 
The R&D investment included in the Scoreboard is the cash 
investment which is funded by the companies themselves. 
It excludes R&D undertaken under contract for customers 
such as governments or other companies. It also excludes 
the companies’ share of any associated company or joint 
venture R&D investment when disclosed. Where part or all 
of R&D costs have been capitalised, the additions to the 
appropriate intangible assets are included to calculate the 
cash investment and any amortisation eliminated.
Companies are allocated to the country of their registered 
office. In some cases this is different from the operational 
or R&D headquarters. This means that the results are 
independent of the actual location of the R&D activity. 
Companies are in industry sectors according to the NACE 
Rev. 224 and the ICB (Industry Classification Benchmark).
Limitations
The Scoreboard relies on disclosure of R&D investment 
in published annual reports and accounts. Therefore, 
companies which do not disclose figures for R&D investment 
or which disclose only figures which are not material enough 
are not included in the Scoreboard. Due to different national 
accounting standards and disclosure practice, companies of 
some countries are less likely than others to disclose R&D 
investment consistently. 
In some countries, R&D costs are very often integrated with 
other operational costs and can therefore not be identified 
separately. For example, companies from many Southern 
European countries or the new Member States are under-
represented in the Scoreboard. On the other side, UK 
companies are over-represented in the Scoreboard. 
For listed companies, country representation will improve 
with IFRS adoption.
The R&D investment disclosed in some companies’ accounts 
follows the US practice of including engineering costs 
relating to product improvement. Where these engineering 
costs have been disclosed separately, they have been 
excluded from the Scoreboard. However, the incidence of 
non-disclosure is uncertain and the impact of this practice is 
a possible overstatement of some overseas R&D investment 
figures in comparison with the EU. 
Where R&D income can be clearly identified as a result of 
customer contracts it is deducted from the R&D expense 
stated in the annual report, so that the R&D investment 
included in the Scoreboard excludes R&D undertaken under 
contract for customers such as governments or other 
companies. However, the disclosure practise differs and R&D 
income from customer contracts cannot always be clearly 
24 NACE is the acronyme for “Nomenclature statistique des activités économiques 
dans la Communauté européenne”.
Annex 2 - Methodological notes
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identified.  This means a possible overstatement of some 
R&D investment figures in the Scoreboard for companies 
with directly R&D related income where this is not disclosed 
in the annual report.
In implementing the definition of R&D, companies exhibit 
variability arising from a number of sources: i) different 
interpretations of the R&D definition. Some companies view 
a process as an R&D process while other companies may 
view the same process as an engineering or other process; ii) 
different companies’ information systems for measuring the 
costs associated with R&D processes; iii) different countries’ 
fiscal treatment of costs.
Interpretation
There are some fundamental aspects of the Scoreboard 
which affect their interpretation.
The focus of the Scoreboard on R&D investment as reported 
in group accounts means that the results can be independent 
of the location of the R&D activity. The Scoreboard indicates 
the level of R&D funded by companies, not all of which is 
carried out in the country in which the company is registered. 
This enables inputs such as R&D and Capex investment to 
be related to outputs such as Sales, Profit, productivity ratios 
and market capitalisation. 
The data used for the Scoreboard are different from data 
provided by statistical offices, e.g. BERD data. The Scoreboard 
refers to all R&D financed by a particular company from 
its own funds, regardless of where that R&D activity is 
performed. BERD refers to all R&D activities performed by 
businesses within a particular sector and territory, regardless 
of the location of the business’s headquarters, and regardless 
of the sources of finance. 
Further, the Scoreboard collects data from audited financial 
accounts and reports. BERD typically takes a stratified 
sample, covering all large companies and a representative 
sample of smaller companies. Additional differences concern 
the definition of R&D intensity (BERD uses the percentage of 
value added, while the Scoreboard measures it as the R&D/
Sales ratio) and the sectoral classification they use (BERD 
follows NACE, the European statistical classification of 
economic sectors, while the Scoreboard classifies companies’ 
economic activities according to the ICB classification).
Sudden changes in R&D figures may arise because a change 
in company accounting standards. For example, the first time 
adoption of IFRS25, may lead to information discontinuities 
due to the different treatment of R&D, i.e. R&D capitalisation 
criteria are stricter and, where the criteria are met, the 
amounts must be capitalised. 
For many highly diversified companies, the R&D investment 
disclosed in their accounts relates only to part of their 
activities, whereas sales and profits are in respect of all their 
activities. Unless such groups disclose their R&D investment 
additional to the other information in segmental analyses, it 
is not possible to relate the R&D more closely to the results 
of the individual activities which give rise to it. The impact 
of this is that some statistics for these groups, e.g. R&D as 
a percentage of sales, are possibly underestimated and so 
comparisons with non-diversified groups are limited.
At the aggregate level, the growth statistics reflect the growth 
of the set of companies in the current year set. Companies 
which may have existed in the base year but which are 
not represented in the current year set are not part of the 
Scoreboard (a company may continue to be represented in 
the current year set if it has been acquired by or merged 
with another). 
For companies outside the Euro area, all currency amounts 
have been translated at the Euro exchange rates ruling at 
31 December 2013 as shown in Table A3.1. The exchange 
rate conversion also applies to the historical data. The 
result is that over time the Scoreboard reflects the domestic 
currency results of the companies rather than economic 
estimates of current purchasing parity results. The original 
domestic currency data can be derived simply by reversing 
the translations at the rates above. Users can then apply 
their own preferred current purchasing parity transformation 
models. 
 
25 Since 2005, the European Union requires all listed companies in the EU to prepare 
their consolidated financial statements according to IFRS (International Financial 
Reporting Standards, see: http://www.iasb.org/). 
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Glossary of definitions
1. Research and Development (R&D) investment in the 
Scoreboard is the cash investment funded by the companies 
themselves. It excludes R&D undertaken under contract for 
customers such as governments or other companies. It also 
excludes the companies’ share of any associated company 
or joint venture R&D investment. Being that disclosed in the 
annual report and accounts, it is subject to the accounting 
definitions of R&D. For example, a definition is set out in 
International Accounting Standard (IAS) 38 “Intangible assets” 
and is based on the OECD “Frascati” manual. Research is 
defined as original and planned investigation undertaken 
with the prospect of gaining new scientific or technical 
knowledge and understanding. Expenditure on research is 
recognised as an expense when it is incurred. Development 
is the application of research findings or other knowledge to 
a plan or design for the production of new or substantially 
improved materials, devices, products, processes, systems or 
services before the start of commercial production or use. 
Development costs are capitalised when they meet certain 
criteria and when it can be demonstrated that the asset will 
generate probable future economic benefits. Where part or 
all of R&D costs have been capitalised, the additions to the 
appropriate intangible assets are included to calculate the 
cash investment and any amortisation eliminated.
2. Net sales follow the usual accounting definition of sales, 
excluding sales taxes and shares of sales of joint ventures 
& associates. For banks, sales are defined as the “Total 
(operating) income” plus any insurance income. For insurance 
companies, sales are defined as “Gross premiums written” 
plus any banking income.
3. R&D intensity is the ratio between R&D investment and 
net sales of a given company or group of companies. At the 
aggregate level, R&D intensity is calculated only by those 
companies for which data exist for both R&D and net sales 
Table A3.1.  Euro exchange rates applied to Scoreboard data of companies based in different currency areas 
(as of 31 Dec 2013).
Country As of 31 Dec 2012 As of 31 Dec 2013
Australia $ 1.27 $ 1.56
Brazil 2.69 Brazilian real 3.25 Brazilian real
Canada $ 1.31 $ 1.47
China 8.30 Renminbi 8.42 Renminbi
Czech Republic 25.14 Koruna 27.43 Koruna
Croatia 7.55 Kuna 7.63 Kuna
Denmark 7.47 Danish Kronor 7.46 Danish Kronor
Hungary 291.54 Forint 297.62 Forint
India 72.25 Indian Rupee 85.40 Indian Rupee
Israel 4.92 Shekel 4.79 Shekel
Japan 114.15  Yen 145.14  Yen
Mexico 17.16 Mexican Peso 18.03 Mexican Peso
Norway 7.35 Norwegian Kronor 8.38 Norwegian Kronor
Poland 4.09 Zloty 4.15 Zloty
Russia 40.08 Rouble 45.15 Rouble
South Korea 1408.45 Won 1449.28 Won
Sweden 8.58 Swedish Kronor 8.86 Swedish Kronor
Switzerland 1.21 Swiss Franc 1.23 Swiss Franc
Turkey 2.35 Turkish lira 2.95 Turkish lira
UK £ 0.84 £ 0.84
USA $ 1.32 $ 1.38
Taiwan $ 38.28 $ 41.42
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in the specified year. The calculation of R&D intensity in the 
Scoreboard is different from than in official statistics, e.g. 
BERD, where R&D intensity is based on value added instead 
of net sales. 
4. Operating profit is calculated as profit (or loss) before 
taxation, plus net interest cost (or minus net interest income) 
minus government grants, less gains (or plus losses) arising 
from the sale/disposal of businesses or fixed assets.
5. One-year growth is simple growth over the previous 
year, expressed as a percentage: 1 yr growth = 100*((C/B)-
1); where C = current year amount and B = previous year 
amount. 1yr growth is calculated only if data exist for both 
the current and previous year. At the aggregate level, 1yr 
growth is calculated only by aggregating those companies 
for which data exist for both the current and previous year.
6. Three-year growth is the compound annual growth 
over the previous three years, expressed as a percentage: 
3 yr growth = 100*(((C/B)^(1/t))-1); where C = current year 
amount, B = base year amount (where base year = current 
year - 3), and t = number of time periods (= 3). 3yr growth is 
calculated only if data exist for the current and base years. 
At the aggregate level, 3yr growth is calculated only by 
aggregating those companies for which data exist for the 
current and base years.
7. Capital expenditure (Capex) is expenditure used by 
a company to acquire or upgrade physical assets such as 
equipment, property, industrial buildings. In accounts capital 
expenditure is added to an asset account (i.e. capitalised), 
thus increasing the asset’s base. It is disclosed in accounts 
as additions to tangible fixed assets.
8. Number of employees is the total consolidated average 
employees or year-end employees if average not stated.
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The 2014 Scoreboard comprises two data samples:
• The world’s top 2500 companies that invested more than 
€15.5m in R&D in 2013.
• The top 1000 R&D investing companies based in the EU 
with R&D investment exceeding €5.0m.
For each company the following information is available: 
• Company identification (name, country of registration and 
sector of declared activity according to ICB classifications).
• R&D investment 
• Net Sales 
• Capital expenditure 
• Operating profit or loss 
• Total number of employees
• Main company indicators (R&D intensity, Capex intensity, 
Profitability)
• Growth rates of main indicators over one year and three 
years.
The following links provide access to the two Scoreboard 
data samples containing the main economic and financial 
indicators and main statistics over the past four years.
R&D ranking of world top 2500 companies: 
http://iri .jrc.ec.europa.eu/documents/10180/354280/
Scoreboard%202014%20Ranking%202500
R&D ranking of EU top 1000 companies: 
http://iri .jrc.ec.europa.eu/documents/10180/354280/
Scoreboard%202014%20EU%201000
Annex 4 - Access to the full 
dataset
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Abstract
The 2014 “EU Industrial R&D Investment Scoreboard” (the Scoreboard) contains economic and financial data for the world’s top 
2500 companies ranked by their investments in Research and Development (R&D). The sample contains 633 companies based 
in the EU and 1867 companies based elsewhere. The Scoreboard data are drawn from the latest available companies’ accounts, 
i.e. usually the fiscal year 2013/14.
Key findings of the 2014 Scoreboard comprise:
- The world top 2500 R&D investors continued to increase their investment in R&D (4.9%), well above the growth of net sales 
(2.8%). The 633 EU companies increased R&D by 2.6% and decreased sales by 2.0%.
- Volkswagen leads the global ranking for the second consecutive year, showing again a remarkable increase of R&D (23.4%, 
up to €11.7bn). Second continues to be Samsung, showing also an impressive R&D increase of 25.4%.
- EU companies in the automobile sector, accounting for one quarter of the total EU’s R&D, continued to increase significantly 
their R&D (6.2%). This reflects the good performance of automobiles companies based in Germany (9.7%) that account for three 
quarters of this sector’s R&D in the EU.
- The  poor R&D performance of EU companies in high-tech sectors such as Pharmaceuticals (0.9%) and Technology Hardware 
and equipment (-5.4%) weighed down the total R&D increase of the EU sample. The overall amount invested in R&D by EU 
companies in high-tech sectors represents 40% of the amount invested by their US counterparts and the gap between the two 
company samples is increasing with time.
EU R&D SCOREBOARD
The 2014 EU Industrial R&D
Investment Scoreboard
Th
e 
20
14
 E
U 
In
du
str
ial
 R
&D
 In
ve
stm
en
t S
co
re
bo
ar
d
LF-NA-26903-EN-N
As the Commission’s in-house science service, the Joint Research Centre’s mission is to provide EU policies with independent, 
evidence-based scientific and technical support throughout the whole policy cycle.
Working in close cooperation with policy Directorates-General, the JRC addresses key societal challenges while stimulating 
innovation through developing new standards, methods and tools, and sharing and transferring its know-how to the 
Member States and international community.
Key policy areas include: environment and climate change; energy and transport; agriculture and food security; health and 
consumer protection; information society and digital agenda; safety and security including nuclear; all supported through 
a cross-cutting and multidisciplinary approach.
Report EUR 26903 EN
doi:10.2791/13983
ISBN 978-92-79-43860-8
